{"subnetworks": [{"diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER", "EPILEPSY", "SEIZURES", "ANXIETY", "PAIN", "HEART DISEASE", "INJURY", "DRUG DEPENDENCE", "NEUROPATHIC PAIN", "MARIJUANA DEPENDENCE", "LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "CORONARY ARTERY DISEASE", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION", "DEMENTIA", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "STROKE", "DRAVET SYNDROME", "LENNOX-GASTAUT SYNDROME", "OPIOID DEPENDENCE", "INGUINAL HERNIA", "FEVER", "CANCER", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "ACUTE RESPIRATORY DISTRESS SYNDROME", "ACUTE KIDNEY INJURY", "POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA", "PARKINSON'S DISEASE", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "LIVER DISEASE", "MULTIPLE SYSTEM ATROPHY", "PROSTATE ADENOCARCINOMA", "PICK DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER", "BRAIN NEOPLASM", "EATING DISORDER", "PROSTATE CARCINOMA", "SICKLE CELL ANEMIA", "FATIGUE", "FIBROMYALGIA", "LUNG CARCINOMA", "MOOD DISORDER", "CARDIAC ARRHYTHMIA", "DIABETIC NEUROPATHY", "COMMON COLD", "PSORIASIS", "ATOPIC ECZEMA", "GASTROPARESIS", "BREAST CARCINOMA", "GASTRIC ADENOCARCINOMA", "GASTRIC CARCINOMA", "MELANOMA", "METASTATIC MELANOMA", "NON-SMALL CELL LUNG CARCINOMA", "CERVICAL CARCINOMA", "NEOPLASM", "OVARIAN CARCINOMA", "CORONARY RESTENOSIS", "SMALL CELL LUNG CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "SQUAMOUS CELL CARCINOMA", "KAPOSI'S SARCOMA", "MULTIPLE MYELOMA", "PANCREATIC CARCINOMA", "ESOPHAGEAL CARCINOMA", "PERIPHERAL VASCULAR DISEASE", "THYROID CARCINOMA", "UTERINE NEOPLASM", "BREAST NEOPLASM", "GLIOBLASTOMA MULTIFORME", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "HEPATOCELLULAR CARCINOMA", "MALE BREAST CARCINOMA", "CUTANEOUS MELANOMA", "BLADDER CARCINOMA", "ENDOMETRIAL NEOPLASM", "GASTROINTESTINAL STROMAL TUMOR", "MERKEL CELL SKIN CANCER", "PERITONEAL NEOPLASM", "SARCOMA", "PERIPHERAL ARTERIAL DISEASE", "PANCREATIC NEOPLASM", "CARCINOMA", "APHTHOUS ULCER", "ACUTE CORONARY SYNDROME", "GOUT", "BEHCET'S SYNDROME", "FAMILIAL MEDITERRANEAN FEVER", "VASCULAR DISEASE", "DIABETIC NEPHROPATHY", "OSTEOARTHRITIS", "CHRONIC HEPATITIS C INFECTION", "ATRIAL FIBRILLATION", "PERICARDITIS", "ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE MYELOID LEUKEMIA", "DEDIFFERENTIATED LIPOSARCOMA", "TESTICULAR CARCINOMA", "STOMACH NEOPLASM", "CLEAR CELL RENAL CARCINOMA", "LEIOMYOSARCOMA", "OSTEOSARCOMA", "LYMPHOMA", "SALIVARY GLAND NEOPLASM", "HODGKINS LYMPHOMA", "GERM CELL TUMOR", "ACUTE GRAFT VS. HOST DISEASE", "NON-HODGKINS LYMPHOMA", "LYMPHOID NEOPLASM", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ANAPLASTIC LARGE CELL LYMPHOMA", "MYCOSIS FUNGOIDES", "COGNITIVE IMPAIRMENT", "PROGRESSIVE SUPRANUCLEAR PALSY", "COLORECTAL CANCER", "NASOPHARYNGEAL NEOPLASM", "UPPER AERODIGESTIVE TRACT NEOPLASM", "METASTATIC PROSTATE CANCER", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "SUICIDAL IDEATION", "TINNITUS", "MENOPAUSE", "AUTISM", "IRRITABLE BOWEL SYNDROME", "CONSTIPATION", "HIV INFECTION", "PORTAL HYPERTENSION", "TORTICOLLIS", "ESSENTIAL TREMOR", "FAMILIAL DYSAUTONOMIA", "CEREBRAL PALSY", "HYPERHIDROSIS", "SPASTICITY", "BENIGN ESSENTIAL BLEPHAROSPASM", "BENIGN PROSTATIC HYPERPLASIA", "PREMATURE EJACULATION", "ACNE", "STRABISMUS", "VAGINISMUS", "CARPAL TUNNEL SYNDROME", "URINARY RETENTION", "MUSCULAR DISEASE", "PROSTATITIS", "INFERTILITY", "NEUROGENIC BLADDER", "URINARY INCONTINENCE", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "RESTLESS LEGS SYNDROME", "SKIN AGING", "RAYNAUD DISEASE", "TRIGEMINAL NEURALGIA", "ROSACEA", "DROOLING", "NERVOUS SYSTEM DISEASE", "NARCOLEPSY WITH CATAPLEXY", "ORTHOSTATIC HYPOTENSION", "SLEEP APNEA", "EWING SARCOMA", "HYPERSOMNIA", "NOCTURIA", "AUTISM SPECTRUM DISORDER", "PULMONARY HYPERTENSION", "HUNTINGTON DISEASE", "TOURETTE SYNDROME", "MOVEMENT DISORDER", "GAUCHER DISEASE", "PSYCHOSIS", "DIABETIC RETINOPATHY", "CHRONIC MYELOGENOUS LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHANGIOLEIOMYOMATOSIS", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "SYSTEMIC SCLERODERMA", "MALIGNANT PLEURAL MESOTHELIOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "MESOTHELIOMA", "POLYCYTHEMIA VERA", "CHOLANGIOCARCINOMA", "CHRONIC KIDNEY DISEASE", "GLIOSARCOMA", "PLEXIFORM NEUROFIBROMA", "MALIGNANT PERIPHERAL NERVE SHEATH TUMOR", "ASTHMA", "NEUROFIBROMATOSIS TYPE 1", "CHONDROSARCOMA", "TYPE I DIABETES MELLITUS", "HYPEREOSINOPHILIC SYNDROME", "ADENOID CYSTIC CARCINOMA", "BILE DUCT CARCINOMA", "OVARIAN NEOPLASM", "RECTUM CANCER", "CYSTIC FIBROSIS", "MANTLE CELL LYMPHOMA", "IDIOPATHIC PULMONARY FIBROSIS", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "NEUROBLASTOMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "DIARRHEA", "RHEUMATOID ARTHRITIS", "GENICULATE HERPES ZOSTER", "CARDIOVASCULAR DISEASE", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "ATHEROSCLEROSIS", "ACUTE LUNG INJURY", "CROHN'S DISEASE", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "THYROID NEOPLASM", "ACTINIC KERATOSIS", "ENDOMETRIOSIS", "CHRONIC PANCREATITIS", "OSTEOARTHRITIS, HIP", "SCIATICA", "OSTEOARTHRITIS, KNEE", "PRURITUS", "SCOLIOSIS", "LUMBAR DISC DEGENERATION", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "SPONTANEOUS ABORTION", "VOMITING", "NEUROPATHY", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "BONE FRACTURE", "DRY EYE SYNDROME", "COUGH", "PREGNANCY", "REFLEX SYMPATHETIC DYSTROPHY", "RENAL INSUFFICIENCY", "BRAIN ANEURYSM", "ANAL FISSURE", "KIDNEY STONE", "SKIN DISEASE", "ANGINA PECTORIS", "INTRACEREBRAL HEMORRHAGE", "PROTEINURIA", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "HYPERLIPIDEMIA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3"], "links": [{"source": "ENSG00000005893", "target": "ENSG00000154277"}, {"source": "ENSG00000022355", "target": "ENSG00000073969"}, {"source": "ENSG00000022355", "target": "ENSG00000109158"}, {"source": "ENSG00000022355", "target": "ENSG00000113327"}, {"source": "ENSG00000022355", "target": "ENSG00000114859"}, {"source": "ENSG00000022355", "target": "ENSG00000145863"}, {"source": "ENSG00000022355", "target": "ENSG00000145864"}, {"source": "ENSG00000022355", "target": "ENSG00000151834"}, {"source": "ENSG00000022355", "target": "ENSG00000163288"}, {"source": "ENSG00000022355", "target": "ENSG00000166206"}, {"source": "ENSG00000022355", "target": "ENSG00000182256"}, {"source": "ENSG00000022355", "target": "ENSG00000186297"}, {"source": "ENSG00000064692", "target": "ENSG00000074317"}, {"source": "ENSG00000064692", "target": "ENSG00000145335"}, {"source": "ENSG00000064692", "target": "ENSG00000158828"}, {"source": "ENSG00000064692", "target": "ENSG00000185345"}, {"source": "ENSG00000069535", "target": "ENSG00000093010"}, {"source": "ENSG00000069535", "target": "ENSG00000123454"}, {"source": "ENSG00000069535", "target": "ENSG00000132437"}, {"source": "ENSG00000069535", "target": "ENSG00000141744"}, {"source": "ENSG00000069535", "target": "ENSG00000150540"}, {"source": "ENSG00000073969", "target": "ENSG00000094755"}, {"source": "ENSG00000073969", "target": "ENSG00000102287"}, {"source": "ENSG00000073969", "target": "ENSG00000109158"}, {"source": "ENSG00000073969", "target": "ENSG00000113327"}, {"source": "ENSG00000073969", "target": "ENSG00000120251"}, {"source": "ENSG00000073969", "target": "ENSG00000145863"}, {"source": "ENSG00000073969", "target": "ENSG00000145864"}, {"source": "ENSG00000073969", "target": "ENSG00000151834"}, {"source": "ENSG00000073969", "target": "ENSG00000163285"}, {"source": "ENSG00000073969", "target": "ENSG00000163288"}, {"source": "ENSG00000073969", "target": "ENSG00000166206"}, {"source": "ENSG00000073969", "target": "ENSG00000186297"}, {"source": "ENSG00000073969", "target": "ENSG00000187730"}, {"source": "ENSG00000093010", "target": "ENSG00000123454"}, {"source": "ENSG00000093010", "target": "ENSG00000132437"}, {"source": "ENSG00000093010", "target": "ENSG00000141744"}, {"source": "ENSG00000100225", "target": "ENSG00000158828"}, {"source": "ENSG00000100225", "target": "ENSG00000185345"}, {"source": "ENSG00000100505", "target": "ENSG00000132639"}, {"source": "ENSG00000103546", "target": "ENSG00000145335"}, {"source": "ENSG00000104833", "target": "ENSG00000188906"}, {"source": "ENSG00000105464", "target": "ENSG00000150672"}, {"source": "ENSG00000105464", "target": "ENSG00000152578"}, {"source": "ENSG00000105464", "target": "ENSG00000155511"}, {"source": "ENSG00000105464", "target": "ENSG00000161509"}, {"source": "ENSG00000105464", "target": "ENSG00000176884"}, {"source": "ENSG00000105464", "target": "ENSG00000183454"}, {"source": "ENSG00000105737", "target": "ENSG00000120251"}, {"source": "ENSG00000105737", "target": "ENSG00000163873"}, {"source": "ENSG00000105737", "target": "ENSG00000164418"}, {"source": "ENSG00000107295", "target": "ENSG00000159082"}, {"source": "ENSG00000107295", "target": "ENSG00000188906"}, {"source": "ENSG00000107295", "target": "ENSG00000204842"}, {"source": "ENSG00000107859", "target": "ENSG00000116288"}, {"source": "ENSG00000108387", "target": "ENSG00000145335"}, {"source": "ENSG00000108576", "target": "ENSG00000145335"}, {"source": "ENSG00000109158", "target": "ENSG00000113327"}, {"source": "ENSG00000109158", "target": "ENSG00000145863"}, {"source": "ENSG00000109158", "target": "ENSG00000145864"}, {"source": "ENSG00000109158", "target": "ENSG00000151834"}, {"source": "ENSG00000109158", "target": "ENSG00000163288"}, {"source": "ENSG00000109158", "target": "ENSG00000166206"}, {"source": "ENSG00000109158", "target": "ENSG00000182256"}, {"source": "ENSG00000109158", "target": "ENSG00000186297"}, {"source": "ENSG00000109738", "target": "ENSG00000114859"}, {"source": "ENSG00000112530", "target": "ENSG00000185345"}, {"source": "ENSG00000113327", "target": "ENSG00000114859"}, {"source": "ENSG00000113327", "target": "ENSG00000145863"}, {"source": "ENSG00000113327", "target": "ENSG00000145864"}, {"source": "ENSG00000113327", "target": "ENSG00000151834"}, {"source": "ENSG00000113327", "target": "ENSG00000163288"}, {"source": "ENSG00000113327", "target": "ENSG00000166206"}, {"source": "ENSG00000113327", "target": "ENSG00000182256"}, {"source": "ENSG00000113327", "target": "ENSG00000186297"}, {"source": "ENSG00000114859", "target": "ENSG00000166206"}, {"source": "ENSG00000114859", "target": "ENSG00000187730"}, {"source": "ENSG00000116032", "target": "ENSG00000120251"}, {"source": "ENSG00000116032", "target": "ENSG00000152578"}, {"source": "ENSG00000116032", "target": "ENSG00000155511"}, {"source": "ENSG00000116032", "target": "ENSG00000176884"}, {"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000116032", "target": "ENSG00000198785"}, {"source": "ENSG00000116288", "target": "ENSG00000126432"}, {"source": "ENSG00000116288", "target": "ENSG00000145335"}, {"source": "ENSG00000116288", "target": "ENSG00000158828"}, {"source": "ENSG00000116288", "target": "ENSG00000165646"}, {"source": "ENSG00000116288", "target": "ENSG00000185345"}, {"source": "ENSG00000120251", "target": "ENSG00000152578"}, {"source": "ENSG00000120251", "target": "ENSG00000155511"}, {"source": "ENSG00000120251", "target": "ENSG00000164418"}, {"source": "ENSG00000120251", "target": "ENSG00000176884"}, {"source": "ENSG00000120251", "target": "ENSG00000183454"}, {"source": "ENSG00000120251", "target": "ENSG00000198785"}, {"source": "ENSG00000123454", "target": "ENSG00000132437"}, {"source": "ENSG00000123454", "target": "ENSG00000141744"}, {"source": "ENSG00000131095", "target": "ENSG00000160307"}, {"source": "ENSG00000132437", "target": "ENSG00000150540"}, {"source": "ENSG00000132437", "target": "ENSG00000180176"}, {"source": "ENSG00000132639", "target": "ENSG00000165646"}, {"source": "ENSG00000132639", "target": "ENSG00000198722"}, {"source": "ENSG00000132718", "target": "ENSG00000185345"}, {"source": "ENSG00000142319", "target": "ENSG00000145335"}, {"source": "ENSG00000142319", "target": "ENSG00000170775"}, {"source": "ENSG00000142319", "target": "ENSG00000185345"}, {"source": "ENSG00000145335", "target": "ENSG00000154277"}, {"source": "ENSG00000145335", "target": "ENSG00000158828"}, {"source": "ENSG00000145335", "target": "ENSG00000167755"}, {"source": "ENSG00000145335", "target": "ENSG00000171368"}, {"source": "ENSG00000145335", "target": "ENSG00000177628"}, {"source": "ENSG00000145335", "target": "ENSG00000180176"}, {"source": "ENSG00000145335", "target": "ENSG00000185345"}, {"source": "ENSG00000145335", "target": "ENSG00000186868"}, {"source": "ENSG00000145335", "target": "ENSG00000188906"}, {"source": "ENSG00000145863", "target": "ENSG00000145864"}, {"source": "ENSG00000145863", "target": "ENSG00000151834"}, {"source": "ENSG00000145863", "target": "ENSG00000163288"}, {"source": "ENSG00000145863", "target": "ENSG00000166206"}, {"source": "ENSG00000145863", "target": "ENSG00000182256"}, {"source": "ENSG00000145863", "target": "ENSG00000186297"}, {"source": "ENSG00000145864", "target": "ENSG00000151834"}, {"source": "ENSG00000145864", "target": "ENSG00000163288"}, {"source": "ENSG00000145864", "target": "ENSG00000166206"}, {"source": "ENSG00000145864", "target": "ENSG00000182256"}, {"source": "ENSG00000145864", "target": "ENSG00000186297"}, {"source": "ENSG00000149403", "target": "ENSG00000164418"}, {"source": "ENSG00000150672", "target": "ENSG00000176884"}, {"source": "ENSG00000150672", "target": "ENSG00000183454"}, {"source": "ENSG00000151834", "target": "ENSG00000163288"}, {"source": "ENSG00000151834", "target": "ENSG00000166206"}, {"source": "ENSG00000151834", "target": "ENSG00000182256"}, {"source": "ENSG00000151834", "target": "ENSG00000186297"}, {"source": "ENSG00000152578", "target": "ENSG00000155511"}, {"source": "ENSG00000152578", "target": "ENSG00000176884"}, {"source": "ENSG00000152578", "target": "ENSG00000183454"}, {"source": "ENSG00000152578", "target": "ENSG00000198785"}, {"source": "ENSG00000154237", "target": "ENSG00000188906"}, {"source": "ENSG00000155511", "target": "ENSG00000161509"}, {"source": "ENSG00000155511", "target": "ENSG00000164418"}, {"source": "ENSG00000155511", "target": "ENSG00000176884"}, {"source": "ENSG00000155511", "target": "ENSG00000183454"}, {"source": "ENSG00000155511", "target": "ENSG00000198785"}, {"source": "ENSG00000158828", "target": "ENSG00000175193"}, {"source": "ENSG00000158828", "target": "ENSG00000185345"}, {"source": "ENSG00000160307", "target": "ENSG00000186868"}, {"source": "ENSG00000161509", "target": "ENSG00000176884"}, {"source": "ENSG00000161509", "target": "ENSG00000183454"}, {"source": "ENSG00000163288", "target": "ENSG00000166206"}, {"source": "ENSG00000163288", "target": "ENSG00000182256"}, {"source": "ENSG00000163288", "target": "ENSG00000186297"}, {"source": "ENSG00000164418", "target": "ENSG00000171189"}, {"source": "ENSG00000164418", "target": "ENSG00000176884"}, {"source": "ENSG00000166206", "target": "ENSG00000182256"}, {"source": "ENSG00000166206", "target": "ENSG00000186297"}, {"source": "ENSG00000170775", "target": "ENSG00000185345"}, {"source": "ENSG00000171189", "target": "ENSG00000176884"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000177628", "target": "ENSG00000185345"}, {"source": "ENSG00000181220", "target": "ENSG00000185345"}, {"source": "ENSG00000182256", "target": "ENSG00000186297"}, {"source": "ENSG00000183454", "target": "ENSG00000198785"}, {"source": "ENSG00000185345", "target": "ENSG00000186868"}, {"source": "ENSG00000185345", "target": "ENSG00000188906"}, {"source": "ENSG00000186868", "target": "ENSG00000188906"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000097007"}, {"source": "ENSG00000097007", "type": "manual", "target": "ENSG00000185345"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000150991", "type": "manual", "target": "ENSG00000185345"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000165059", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000150995", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000072062", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000178372"}, {"source": "ENSG00000178372", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000169885"}, {"source": "ENSG00000169885", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000183943", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000178363"}, {"source": "ENSG00000178363", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000142875", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000198668"}, {"source": "ENSG00000198668", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000089250"}, {"source": "ENSG00000089250", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000174775"}, {"source": "ENSG00000174775", "type": "manual", "target": "ENSG00000254647"}, {"source": "ENSG00000254647", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000186298", "type": "manual", "target": "ENSG00000254647"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000172531", "type": "manual", "target": "ENSG00000109971"}, {"source": "ENSG00000109971", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000152578"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000100151"}, {"source": "ENSG00000100151", "type": "manual", "target": "ENSG00000103546"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000100151"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000164885"}, {"source": "ENSG00000164885", "type": "manual", "target": "ENSG00000159082"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000070808"}, {"source": "ENSG00000070808", "type": "manual", "target": "ENSG00000197943"}, {"source": "ENSG00000197943", "type": "manual", "target": "ENSG00000159082"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000148660"}, {"source": "ENSG00000148660", "type": "manual", "target": "ENSG00000197943"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000058404"}, {"source": "ENSG00000058404", "type": "manual", "target": "ENSG00000197943"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000145349"}, {"source": "ENSG00000145349", "type": "manual", "target": "ENSG00000197943"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000213639", "type": "manual", "target": "ENSG00000107758"}, {"source": "ENSG00000107758", "type": "manual", "target": "ENSG00000159082"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000077522"}, {"source": "ENSG00000077522", "type": "manual", "target": "ENSG00000138798"}, {"source": "ENSG00000138798", "type": "manual", "target": "ENSG00000159082"}, {"source": "ENSG00000105464", "type": "manual", "target": "ENSG00000127914"}, {"source": "ENSG00000127914", "type": "manual", "target": "ENSG00000112640"}, {"source": "ENSG00000112640", "type": "manual", "target": "ENSG00000180176"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000139112", "type": "manual", "target": "ENSG00000161011"}, {"source": "ENSG00000161011", "type": "manual", "target": "ENSG00000185345"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000170296", "type": "manual", "target": "ENSG00000161011"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000034713", "type": "manual", "target": "ENSG00000161011"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000115993", "type": "manual", "target": "ENSG00000147162"}, {"source": "ENSG00000147162", "type": "manual", "target": "ENSG00000166167"}, {"source": "ENSG00000166167", "type": "manual", "target": "ENSG00000100505"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000171723", "type": "manual", "target": "ENSG00000198793"}, {"source": "ENSG00000198793", "type": "manual", "target": "ENSG00000100644"}, {"source": "ENSG00000100644", "type": "manual", "target": "ENSG00000005893"}, {"source": "ENSG00000105737", "type": "manual", "target": "ENSG00000164418"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000075711", "type": "manual", "target": "ENSG00000185345"}, {"source": "ENSG00000105737", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000082458", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000105737", "type": "manual", "target": "ENSG00000152208"}, {"source": "ENSG00000152208", "type": "manual", "target": "ENSG00000047932"}, {"source": "ENSG00000047932", "type": "manual", "target": "ENSG00000135823"}, {"source": "ENSG00000135823", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000105737", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000105737", "type": "manual", "target": "ENSG00000163873"}, {"source": "ENSG00000163873", "type": "manual", "target": "ENSG00000149782"}, {"source": "ENSG00000149782", "type": "manual", "target": "ENSG00000123104"}, {"source": "ENSG00000123104", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000151834"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000106976"}, {"source": "ENSG00000106976", "type": "manual", "target": "ENSG00000107295"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000186297"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000106976"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000106976"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000145863"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000106976"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000114859"}, {"source": "ENSG00000114859", "type": "manual", "target": "ENSG00000001626"}, {"source": "ENSG00000001626", "type": "manual", "target": "ENSG00000109971"}, {"source": "ENSG00000166206", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000100568"}, {"source": "ENSG00000100568", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000170310"}, {"source": "ENSG00000170310", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000117758"}, {"source": "ENSG00000117758", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000079950"}, {"source": "ENSG00000079950", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000135823"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000106089"}, {"source": "ENSG00000106089", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000162236"}, {"source": "ENSG00000162236", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000103496"}, {"source": "ENSG00000103496", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000099940"}, {"source": "ENSG00000099940", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000105402"}, {"source": "ENSG00000105402", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000108587"}, {"source": "ENSG00000108587", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000196961"}, {"source": "ENSG00000196961", "type": "manual", "target": "ENSG00000107295"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000100151"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000101558"}, {"source": "ENSG00000101558", "type": "manual", "target": "ENSG00000220205"}, {"source": "ENSG00000220205", "type": "manual", "target": "ENSG00000165646"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000092108"}, {"source": "ENSG00000092108", "type": "manual", "target": "ENSG00000220205"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000092531"}, {"source": "ENSG00000092531", "type": "manual", "target": "ENSG00000220205"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000102189"}, {"source": "ENSG00000102189", "type": "manual", "target": "ENSG00000112062"}, {"source": "ENSG00000112062", "type": "manual", "target": "ENSG00000180176"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000105393"}, {"source": "ENSG00000105393", "type": "manual", "target": "ENSG00000126432"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000135018"}, {"source": "ENSG00000135018", "type": "manual", "target": "ENSG00000142192"}, {"source": "ENSG00000142192", "type": "manual", "target": "ENSG00000160307"}, {"source": "ENSG00000114859", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000114859", "type": "manual", "target": "ENSG00000187730"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000114859", "type": "manual", "target": "ENSG00000166206"}, {"source": "ENSG00000114859", "type": "manual", "target": "ENSG00000113327"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000114859"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000105464"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000010810"}, {"source": "ENSG00000010810", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000178372"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000198668"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000089250"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000120899"}, {"source": "ENSG00000120899", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000174775"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000148660"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000077522"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000058404"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000154229"}, {"source": "ENSG00000154229", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000197122"}, {"source": "ENSG00000197122", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000145349"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000123384"}, {"source": "ENSG00000123384", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000169885"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000178363"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000189056"}, {"source": "ENSG00000189056", "type": "manual", "target": "ENSG00000131711"}, {"source": "ENSG00000131711", "type": "manual", "target": "ENSG00000116288"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000157193"}, {"source": "ENSG00000157193", "type": "manual", "target": "ENSG00000131711"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000070808"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000150672"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000178568"}, {"source": "ENSG00000178568", "type": "manual", "target": "ENSG00000107295"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000113319"}, {"source": "ENSG00000113319", "type": "manual", "target": "ENSG00000067900"}, {"source": "ENSG00000067900", "type": "manual", "target": "ENSG00000107295"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000058335"}, {"source": "ENSG00000058335", "type": "manual", "target": "ENSG00000134259"}, {"source": "ENSG00000134259", "type": "manual", "target": "ENSG00000107295"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000152578"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000127914"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000006116"}, {"source": "ENSG00000006116", "type": "manual", "target": "ENSG00000151067"}, {"source": "ENSG00000151067", "type": "manual", "target": "ENSG00000079841"}, {"source": "ENSG00000079841", "type": "manual", "target": "ENSG00000165646"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000105605"}, {"source": "ENSG00000105605", "type": "manual", "target": "ENSG00000151067"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000166862", "type": "manual", "target": "ENSG00000151067"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000142408"}, {"source": "ENSG00000142408", "type": "manual", "target": "ENSG00000151067"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000075429"}, {"source": "ENSG00000075429", "type": "manual", "target": "ENSG00000112640"}, {"source": "ENSG00000183454", "type": "manual", "target": "ENSG00000075461"}, {"source": "ENSG00000075461", "type": "manual", "target": "ENSG00000112640"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000151834"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000186297"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000145863"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000145864", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000135018"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000145863", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000149403", "type": "manual", "target": "ENSG00000164418"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000164418"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000070808"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000145349"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000006116"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000148660"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000168036"}, {"source": "ENSG00000168036", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000198561"}, {"source": "ENSG00000198561", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000044115"}, {"source": "ENSG00000044115", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000058404"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000075461"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000142408"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000254087"}, {"source": "ENSG00000254087", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000130522"}, {"source": "ENSG00000130522", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000170558"}, {"source": "ENSG00000170558", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000170759"}, {"source": "ENSG00000170759", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000125740"}, {"source": "ENSG00000125740", "type": "manual", "target": "ENSG00000164885"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000100151"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000155974"}, {"source": "ENSG00000155974", "type": "manual", "target": "ENSG00000100393"}, {"source": "ENSG00000100393", "type": "manual", "target": "ENSG00000182979"}, {"source": "ENSG00000182979", "type": "manual", "target": "ENSG00000107859"}, {"source": "ENSG00000120251", "type": "manual", "target": "ENSG00000176884"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000198668"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000147044"}, {"source": "ENSG00000147044", "type": "manual", "target": "ENSG00000185345"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000137575"}, {"source": "ENSG00000137575", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000170558"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000152208"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000100151"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000155974"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000176884"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000171189"}, {"source": "ENSG00000171189", "type": "manual", "target": "ENSG00000152413"}, {"source": "ENSG00000152413", "type": "manual", "target": "ENSG00000150995"}, {"source": "ENSG00000164418", "type": "manual", "target": "ENSG00000104863"}, {"source": "ENSG00000104863", "type": "manual", "target": "ENSG00000165029"}, {"source": "ENSG00000165029", "type": "manual", "target": "ENSG00000117758"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000147044"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000105464"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000054523"}, {"source": "ENSG00000054523", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000165029"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000157087"}, {"source": "ENSG00000157087", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000089250"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000131899"}, {"source": "ENSG00000131899", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000176884"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000152208"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000182255"}, {"source": "ENSG00000182255", "type": "manual", "target": "ENSG00000197122"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000166963"}, {"source": "ENSG00000166963", "type": "manual", "target": "ENSG00000140941"}, {"source": "ENSG00000140941", "type": "manual", "target": "ENSG00000158828"}, {"source": "ENSG00000150672", "type": "manual", "target": "ENSG00000170579"}, {"source": "ENSG00000170579", "type": "manual", "target": "ENSG00000088986"}, {"source": "ENSG00000088986", "type": "manual", "target": "ENSG00000104833"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000186297"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000166206"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000113327"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000145864"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000145863"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000109158"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000182256", "type": "manual", "target": "ENSG00000151834"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000006116"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000075461"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000142408"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000152578"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000105605"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000176884"}, {"source": "ENSG00000198785", "type": "manual", "target": "ENSG00000075429"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000135018"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000114859"}, {"source": "ENSG00000022355", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000151834"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000186297"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000145863"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000114859"}, {"source": "ENSG00000113327", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000171189", "type": "manual", "target": "ENSG00000164418"}, {"source": "ENSG00000171189", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000171189", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000171189", "type": "manual", "target": "ENSG00000100151"}, {"source": "ENSG00000171189", "type": "manual", "target": "ENSG00000155974"}, {"source": "ENSG00000171189", "type": "manual", "target": "ENSG00000176884"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000006116"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000075461"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000142408"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000152578"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000105605"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000176884"}, {"source": "ENSG00000116032", "type": "manual", "target": "ENSG00000075429"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000105464"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000148660"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000170759"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000070808"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000006116"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000075461"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000088367"}, {"source": "ENSG00000088367", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000142408"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000155974"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000176884"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000075429"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000105605"}, {"source": "ENSG00000152578", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000186297"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000145863"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000151834"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000109158", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000135018"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000151834", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000151834"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000186297"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000145863"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000163288", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000135018"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000186297", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000109738", "type": "manual", "target": "ENSG00000136295"}, {"source": "ENSG00000136295", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000109738", "type": "manual", "target": "ENSG00000114859"}, {"source": "ENSG00000109738", "type": "manual", "target": "ENSG00000188037"}, {"source": "ENSG00000188037", "type": "manual", "target": "ENSG00000001626"}, {"source": "ENSG00000109738", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000163873", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000163873", "type": "manual", "target": "ENSG00000186469"}, {"source": "ENSG00000186469", "type": "manual", "target": "ENSG00000142192"}, {"source": "ENSG00000163873", "type": "manual", "target": "ENSG00000182621"}, {"source": "ENSG00000182621", "type": "manual", "target": "ENSG00000142192"}, {"source": "ENSG00000163873", "type": "manual", "target": "ENSG00000137841"}, {"source": "ENSG00000137841", "type": "manual", "target": "ENSG00000142192"}, {"source": "ENSG00000163873", "type": "manual", "target": "ENSG00000100151"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000075711"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000254087"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000152413"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000088367"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000069869"}, {"source": "ENSG00000069869", "type": "manual", "target": "ENSG00000185359"}, {"source": "ENSG00000185359", "type": "manual", "target": "ENSG00000132639"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000170759"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000120899"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000070808"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000145349"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000148660"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000058404"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000155974"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000006116"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000075461"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000075429"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000105605"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000142408"}, {"source": "ENSG00000155511", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000105464"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000010810"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000197694"}, {"source": "ENSG00000197694", "type": "manual", "target": "ENSG00000150991"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000178372"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000148660"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000120899"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000174775"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000077522"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000058404"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000154229"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000145349"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000089250"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000070808"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000127914"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000006116"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000075461"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000164418"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000166862"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000142408"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000113319"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000058335"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000150672"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000169885"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000178363"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000120251"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000171189"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000152578"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000105605"}, {"source": "ENSG00000176884", "type": "manual", "target": "ENSG00000075429"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000105464"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000178372"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000213639"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000082458"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000148660"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000058404"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000174775"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000077522"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000145349"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000198668"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000186298"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000155511"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000089250"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000172531"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000070808"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000127914"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000183454"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000113319"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000058335"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000169885"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000161509", "type": "manual", "target": "ENSG00000178363"}], "drugs": [{"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "BREAST NEOPLASM", "stage": 4}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 3}, {"efo_term": "GASTRIC CARCINOMA", "stage": 3}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "METASTATIC MELANOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "CERVICAL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "KAPOSI'S SARCOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 3}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 3}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "PERIPHERAL VASCULAR DISEASE", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "PANCREATIC NEOPLASM", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "CORONARY RESTENOSIS", "stage": 1}, {"efo_term": "THYROID CARCINOMA", "stage": 1}, {"efo_term": "UTERINE NEOPLASM", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 1}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 1}, {"efo_term": "PERITONEAL NEOPLASM", "stage": 1}], "max_phase": 4, "name": "PACLITAXEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428647", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "GASTRIC ADENOCARCINOMA", "GASTRIC CARCINOMA", "MELANOMA", "METASTATIC MELANOMA", "NON-SMALL CELL LUNG CARCINOMA", "CANCER", "CERVICAL CARCINOMA", "LUNG CARCINOMA", "NEOPLASM", "OVARIAN CARCINOMA", "CORONARY RESTENOSIS", "PROSTATE CARCINOMA", "SMALL CELL LUNG CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "SQUAMOUS CELL CARCINOMA", "KAPOSI'S SARCOMA", "MULTIPLE MYELOMA", "PANCREATIC CARCINOMA", "ESOPHAGEAL CARCINOMA", "PERIPHERAL VASCULAR DISEASE", "THYROID CARCINOMA", "UTERINE NEOPLASM", "BREAST NEOPLASM", "GLIOBLASTOMA MULTIFORME", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "HEPATOCELLULAR CARCINOMA", "COLORECTAL ADENOCARCINOMA", "MALE BREAST CARCINOMA", "CUTANEOUS MELANOMA", "BLADDER CARCINOMA", "ENDOMETRIAL NEOPLASM", "GASTROINTESTINAL STROMAL TUMOR", "MERKEL CELL SKIN CANCER", "PERITONEAL NEOPLASM", "SARCOMA", "PERIPHERAL ARTERIAL DISEASE", "PANCREATIC NEOPLASM", "CARCINOMA"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}, {"efo_term": "BENIGN ESSENTIAL BLEPHAROSPASM", "stage": 4}, {"efo_term": "URINARY INCONTINENCE", "stage": 4}, {"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CEREBRAL PALSY", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "STRABISMUS", "stage": 3}, {"efo_term": "VAGINISMUS", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "PROSTATITIS", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "TORTICOLLIS", "stage": 3}, {"efo_term": "NEUROGENIC BLADDER", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "SKIN AGING", "stage": 3}, {"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 2}, {"efo_term": "PREMATURE EJACULATION", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "STOMACH NEOPLASM", "stage": 2}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 2}, {"efo_term": "URINARY RETENTION", "stage": 2}, {"efo_term": "MUSCULAR DISEASE", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "RAYNAUD DISEASE", "stage": 2}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "INJURY", "stage": 1}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 1}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 1}], "max_phase": 4, "name": "BOTULINUM TOXIN TYPE A PURIFIED NEUROTOXIN COMPLEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201574", "mechanisms": ["Synaptosomal-associated protein 25 inhibitor"], "genes": ["SNAP25"], "type": "Unknown", "diseases": ["CEREBRAL PALSY", "HYPERHIDROSIS", "OBESITY", "SPASTICITY", "PAIN", "BENIGN ESSENTIAL BLEPHAROSPASM", "BENIGN PROSTATIC HYPERPLASIA", "MIGRAINE DISORDER", "PREMATURE EJACULATION", "ACNE", "MORBID OBESITY", "STRABISMUS", "STOMACH NEOPLASM", "VAGINISMUS", "CARPAL TUNNEL SYNDROME", "STROKE", "URINARY RETENTION", "INJURY", "MUSCULAR DISEASE", "PROSTATITIS", "NEUROPATHIC PAIN", "TORTICOLLIS", "OSTEOARTHRITIS", "ATRIAL FIBRILLATION", "INFERTILITY", "PARKINSON'S DISEASE", "NEUROGENIC BLADDER", "URINARY INCONTINENCE", "MULTIPLE SCLEROSIS", "UNIPOLAR DEPRESSION", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "RESTLESS LEGS SYNDROME", "ESOPHAGEAL CARCINOMA", "SKIN AGING", "RAYNAUD DISEASE"]}, {"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "METASTATIC MELANOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "CHOLANGIOCARCINOMA", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "DASATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "SRC inhibitor"], "genes": ["ABL1", "FYN", "SRC", "LYN"], "type": "Small molecule", "diseases": ["ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LEUKEMIA", "MULTIPLE MYELOMA", "NON-HODGKINS LYMPHOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "BREAST CARCINOMA", "CHRONIC MYELOGENOUS LEUKEMIA", "PROSTATE CARCINOMA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "GLIOBLASTOMA MULTIFORME", "LUNG CARCINOMA", "METASTATIC MELANOMA", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "CANCER", "MALIGNANT PLEURAL MESOTHELIOMA", "NEOPLASM", "DIFFUSE LARGE B-CELL LYMPHOMA", "MELANOMA", "MESOTHELIOMA", "POLYCYTHEMIA VERA", "BREAST NEOPLASM", "HEPATOCELLULAR CARCINOMA", "LYMPHOMA", "SMALL CELL LUNG CARCINOMA", "PROSTATE ADENOCARCINOMA", "CHOLANGIOCARCINOMA", "CHRONIC KIDNEY DISEASE", "GLIOSARCOMA"]}, {"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1C", "CACNG7", "CACNG2", "CACNG8", "CACNG5", "CACNG4"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 4}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 3}, {"efo_term": "SARCOMA", "stage": 3}, {"efo_term": "PLEXIFORM NEUROFIBROMA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MALIGNANT PERIPHERAL NERVE SHEATH TUMOR", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "CHONDROSARCOMA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 2}, {"efo_term": "HYPEREOSINOPHILIC SYNDROME", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "IMATINIB MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1642", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["CHRONIC MYELOGENOUS LEUKEMIA", "GASTROINTESTINAL STROMAL TUMOR", "PLEXIFORM NEUROFIBROMA", "POLYCYTHEMIA VERA", "PULMONARY HYPERTENSION", "ACUTE LYMPHOBLASTIC LEUKEMIA", "LEUKEMIA", "OVARIAN CARCINOMA", "SARCOMA", "SMALL CELL LUNG CARCINOMA", "SYSTEMIC SCLERODERMA", "MELANOMA", "MALIGNANT PERIPHERAL NERVE SHEATH TUMOR", "ASTHMA", "CENTRAL NERVOUS SYSTEM CANCER", "NEUROFIBROMATOSIS TYPE 1", "CARCINOMA", "GASTRIC CARCINOMA", "CHONDROSARCOMA", "TYPE I DIABETES MELLITUS", "CANCER", "MALE BREAST CARCINOMA", "NEOPLASM", "HYPEREOSINOPHILIC SYNDROME", "MERKEL CELL SKIN CANCER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1C", "CACNG7", "CACNG2", "CACNG8", "CACNG5", "CACNG4"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 4}, {"efo_term": "PROSTATE CARCINOMA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "METASTATIC PROSTATE CANCER", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "UPPER AERODIGESTIVE TRACT NEOPLASM", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "STOMACH NEOPLASM", "stage": 2}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 1}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 1}], "max_phase": 4, "name": "DOCETAXEL HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545252", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "CARCINOMA", "GASTRIC CARCINOMA", "LUNG CARCINOMA", "NASOPHARYNGEAL NEOPLASM", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "UPPER AERODIGESTIVE TRACT NEOPLASM", "BLADDER CARCINOMA", "CANCER", "PANCREATIC CARCINOMA", "OVARIAN CARCINOMA", "LEUKEMIA", "ESOPHAGEAL CARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "BREAST NEOPLASM", "STOMACH NEOPLASM", "SQUAMOUS CELL CARCINOMA", "METASTATIC PROSTATE CANCER", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "DEMENTIA", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "FATIGUE", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 0}, {"efo_term": "PARKINSON'S DISEASE", "stage": 0}], "max_phase": 4, "name": "METHYLPHENIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "BIPOLAR DISORDER", "CANCER", "METAMPHETAMINE DEPENDENCE", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "DEMENTIA", "EATING DISORDER", "MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "PROSTATE CARCINOMA", "SICKLE CELL ANEMIA", "INJURY", "PARKINSON'S DISEASE", "FATIGUE", "ALZHEIMERS DISEASE", "POST-OPERATIVE SIGN OR SYMPTOM", "NICOTINE DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "COLORECTAL CANCER", "stage": 3}, {"efo_term": "ADENOID CYSTIC CARCINOMA", "stage": 2}, {"efo_term": "BILE DUCT CARCINOMA", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "CHOLANGIOCARCINOMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN NEOPLASM", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "THYROID CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "RECTUM CANCER", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}], "max_phase": 4, "name": "REGORAFENIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["COLORECTAL ADENOCARCINOMA", "ADENOID CYSTIC CARCINOMA", "BILE DUCT CARCINOMA", "CANCER", "GASTROINTESTINAL STROMAL TUMOR", "PANCREATIC CARCINOMA", "SARCOMA", "HEPATOCELLULAR CARCINOMA", "CHOLANGIOCARCINOMA", "NEOPLASM", "CARCINOMA", "OVARIAN NEOPLASM", "MELANOMA", "THYROID CARCINOMA", "OVARIAN CARCINOMA", "RECTUM CANCER", "COLORECTAL CANCER", "NON-SMALL CELL LUNG CARCINOMA", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "RESPIRATORY INSUFFICIENCY", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "PROPOFOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "PAIN", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "EPILEPSY", "INJURY", "CORONARY ARTERY DISEASE", "INSOMNIA", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "DEDIFFERENTIATED LIPOSARCOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "TESTICULAR CARCINOMA", "stage": 2}, {"efo_term": "BRAIN NEOPLASM", "stage": 1}], "max_phase": 4, "name": "CABAZITAXEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201748", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "DEDIFFERENTIATED LIPOSARCOMA", "NEOPLASM", "PROSTATE CARCINOMA", "SMALL CELL LUNG CARCINOMA", "BRAIN NEOPLASM", "CARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "PROSTATE ADENOCARCINOMA", "CANCER", "GLIOBLASTOMA MULTIFORME", "GASTRIC CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "OVARIAN CARCINOMA", "TESTICULAR CARCINOMA"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FATIGUE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "EWING SARCOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 1}, {"efo_term": "SLEEP APNEA", "stage": 1}, {"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 0}], "max_phase": 4, "name": "MODAFINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1373", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COCAINE DEPENDENCE", "METAMPHETAMINE DEPENDENCE", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "FATIGUE", "NARCOLEPSY WITH CATAPLEXY", "ORTHOSTATIC HYPOTENSION", "TINNITUS", "POST-TRAUMATIC STRESS DISORDER", "SLEEP APNEA", "EWING SARCOMA", "STROKE", "ALZHEIMERS DISEASE", "OVARIAN CARCINOMA"]}, {"indications": [{"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "HYPERSOMNIA", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "FATIGUE", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "NOCTURIA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}], "max_phase": 4, "name": "ARMODAFINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201192", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ESOPHAGEAL CARCINOMA", "HYPERSOMNIA", "INSOMNIA", "SCHIZOPHRENIA", "NARCOLEPSY WITH CATAPLEXY", "NON-SMALL CELL LUNG CARCINOMA", "UNIPOLAR DEPRESSION", "NEOPLASM", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER", "INJURY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "OBSTRUCTIVE SLEEP APNEA", "FATIGUE", "STROKE", "NOCTURIA"]}, {"indications": [{"efo_term": "THYROID CARCINOMA", "stage": 4}, {"efo_term": "THYROID NEOPLASM", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}, {"efo_term": "OVARIAN CARCINOMA", "stage": 1}, {"efo_term": "NEUROBLASTOMA", "stage": 1}], "max_phase": 4, "name": "VANDETANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor", "Epidermal growth factor receptor inhibitor"], "genes": ["SRC", "ERBB4"], "type": "Small molecule", "diseases": ["MESOTHELIOMA", "CENTRAL NERVOUS SYSTEM CANCER", "PANCREATIC CARCINOMA", "THYROID CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "OVARIAN CARCINOMA", "PROSTATE CARCINOMA", "GASTROINTESTINAL STROMAL TUMOR", "THYROID NEOPLASM", "HEPATOCELLULAR CARCINOMA", "NEOPLASM", "CLEAR CELL RENAL CARCINOMA", "NEUROBLASTOMA", "CANCER", "LUNG CARCINOMA", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["GABA-A receptor; anion channel positive modulator", "Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GRIK5", "GABRA4", "GABRG2", "GRIA2", "GABRA6", "GABRB2", "GRIK4", "GABRA2", "GRIA4", "GRIA1", "GABRG1", "GABRB1", "GRIK3", "GRIK2", "GABRB3", "GRIK1", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "GOUT", "stage": 4}, {"efo_term": "FAMILIAL MEDITERRANEAN FEVER", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PERICARDITIS", "stage": 3}, {"efo_term": "APHTHOUS ULCER", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "BEHCET'S SYNDROME", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 2}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "OBESITY", "stage": 1}], "max_phase": 4, "name": "COLCHICINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["APHTHOUS ULCER", "ACUTE CORONARY SYNDROME", "GOUT", "BEHCET'S SYNDROME", "PROSTATE CARCINOMA", "FAMILIAL MEDITERRANEAN FEVER", "VASCULAR DISEASE", "DIABETIC NEPHROPATHY", "OSTEOARTHRITIS", "CHRONIC HEPATITIS C INFECTION", "CORONARY ARTERY DISEASE", "HEPATOCELLULAR CARCINOMA", "ATRIAL FIBRILLATION", "PERICARDITIS", "OBESITY"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "BREAST NEOPLASM", "stage": 4}, {"efo_term": "SARCOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "OSTEOSARCOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "CERVICAL CARCINOMA", "stage": 2}, {"efo_term": "SALIVARY GLAND NEOPLASM", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 4, "name": "ERIBULIN MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1683544", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "PROSTATE CARCINOMA", "CANCER", "SARCOMA", "OSTEOSARCOMA", "BREAST NEOPLASM", "LYMPHOMA", "PROSTATE ADENOCARCINOMA", "CERVICAL CARCINOMA", "SALIVARY GLAND NEOPLASM"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "STOMACH NEOPLASM", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "LEIOMYOSARCOMA", "stage": 2}], "max_phase": 4, "name": "IXABEPILONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201752", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "CANCER", "ENDOMETRIAL NEOPLASM", "PROSTATE CARCINOMA", "NEOPLASM", "STOMACH NEOPLASM", "MELANOMA", "PROSTATE ADENOCARCINOMA", "CLEAR CELL RENAL CARCINOMA", "SARCOMA", "LEIOMYOSARCOMA"]}, {"indications": [{"efo_term": "HODGKINS LYMPHOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ANAPLASTIC LARGE CELL LYMPHOMA", "stage": 4}, {"efo_term": "GERM CELL TUMOR", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 1}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 1}, {"efo_term": "MYCOSIS FUNGOIDES", "stage": 1}], "max_phase": 4, "name": "BRENTUXIMAB VEDOTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742994", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Antibody", "diseases": ["HODGKINS LYMPHOMA", "GERM CELL TUMOR", "ACUTE GRAFT VS. HOST DISEASE", "LEUKEMIA", "LYMPHOMA", "NON-HODGKINS LYMPHOMA", "LYMPHOID NEOPLASM", "NEOPLASM", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ANAPLASTIC LARGE CELL LYMPHOMA", "MYCOSIS FUNGOIDES"]}, {"indications": [{"efo_term": "LYMPHANGIOLEIOMYOMATOSIS", "stage": 2}, {"efo_term": "OSTEOSARCOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "SARACATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL217092", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "Tyrosine-protein kinase SRC inhibitor"], "genes": ["ABL1", "SRC"], "type": "Small molecule", "diseases": ["LYMPHANGIOLEIOMYOMATOSIS", "OSTEOSARCOMA", "NON-SMALL CELL LUNG CARCINOMA", "CANCER", "PROSTATE CARCINOMA", "MALE BREAST CARCINOMA", "NEOPLASM", "MELANOMA", "ALCOHOL DRINKING", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DEMENTIA", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "LORAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL580", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DEMENTIA", "EPILEPSY", "UNIPOLAR DEPRESSION", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "DRUG DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}, {"efo_term": "HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "SEVOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OBESITY", "ACUTE KIDNEY INJURY", "CANCER", "MORBID OBESITY", "POST-OPERATIVE SIGN OR SYMPTOM", "HEART DISEASE", "INJURY", "CORONARY ARTERY DISEASE", "INFLAMMATION", "CONGENITAL HEART DISEASE"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 3}, {"efo_term": "BENIGN ESSENTIAL BLEPHAROSPASM", "stage": 3}, {"efo_term": "TORTICOLLIS", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "ROSACEA", "stage": 2}, {"efo_term": "DROOLING", "stage": 2}], "max_phase": 4, "name": "INCOBOTULINUMTOXINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108035", "mechanisms": ["Synaptosomal-associated protein 25 inhibitor"], "genes": ["SNAP25"], "type": "Unknown", "diseases": ["PAIN", "SPASTICITY", "ESSENTIAL TREMOR", "BENIGN ESSENTIAL BLEPHAROSPASM", "TORTICOLLIS", "TRIGEMINAL NEURALGIA", "ROSACEA", "STROKE", "DROOLING"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "PROSTATITIS", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 2}], "max_phase": 3, "name": "TANEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108567", "mechanisms": ["Beta-nerve growth factor inhibitor"], "genes": ["NGF"], "type": "Antibody", "diseases": ["ENDOMETRIOSIS", "OSTEOARTHRITIS", "PAIN", "CHRONIC PANCREATITIS", "PROSTATITIS", "OSTEOARTHRITIS, HIP", "CHRONIC INTERSTITIAL CYSTITIS", "DIABETIC NEUROPATHY", "GENICULATE HERPES ZOSTER"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "TORTICOLLIS", "stage": 1}], "max_phase": 4, "name": "PERAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214124", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARKINSON'S DISEASE", "SEIZURES", "TORTICOLLIS", "NEUROPATHIC PAIN", "MIGRAINE DISORDER", "ESSENTIAL TREMOR", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "OSTEOSARCOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 3, "name": "RIDAFOROLIMUS", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103839", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["NEOPLASM", "BREAST CARCINOMA", "CANCER", "SARCOMA", "ENDOMETRIAL NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "PROSTATE CARCINOMA", "OSTEOSARCOMA"]}, {"indications": [{"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "THYROID CARCINOMA", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 1}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "MLN-0128", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545097", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["RENAL CELL CARCINOMA", "MERKEL CELL SKIN CANCER", "HEPATOCELLULAR CARCINOMA", "NEOPLASM", "PROSTATE CARCINOMA", "THYROID CARCINOMA", "ENDOMETRIAL NEOPLASM", "CANCER"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "PRINZMETAL'S ANGINA", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 3}], "max_phase": 4, "name": "AMLODIPINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200402", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CORONARY ARTERY DISEASE", "PROTEINURIA", "ANGINA PECTORIS", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "STROKE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "DEXTROAMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent", "Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3", "SLC18A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COCAINE DEPENDENCE", "METAMPHETAMINE DEPENDENCE", "STROKE", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "ACUTE CORONARY SYNDROME", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ATHEROSCLEROSIS", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 1}], "max_phase": 3, "name": "LOSMAPIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088752", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["ACUTE CORONARY SYNDROME", "NEUROPATHIC PAIN", "CARDIOVASCULAR DISEASE", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ATHEROSCLEROSIS", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "CEREBRAL PALSY", "stage": 1}], "max_phase": 4, "name": "DALFAMPRIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA4"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "MOOD DISORDER", "stage": 1}], "max_phase": 4, "name": "BUPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1698", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION", "LUNG CARCINOMA", "MOOD DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 1}], "max_phase": 4, "name": "VENLAFAXINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201066", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "COCAINE DEPENDENCE", "ANXIETY", "PAIN", "PROSTATE CARCINOMA", "FIBROMYALGIA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "STOMACH NEOPLASM", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}], "max_phase": 4, "name": "VINFLUNINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110725", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["NEOPLASM", "PROSTATE CARCINOMA", "BREAST CARCINOMA", "STOMACH NEOPLASM", "SMALL CELL LUNG CARCINOMA", "CARCINOMA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "CARBIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200748", "mechanisms": ["DOPA decarboxylase inhibitor"], "genes": ["DDC"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "FAMILIAL DYSAUTONOMIA", "FIBROMYALGIA", "SECONDARY PARKINSON DISEASE", "POSTENCEPHALITIC PARKINSON DISEASE", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}, {"efo_term": "RENAL CARCINOMA", "stage": 1}], "max_phase": 2, "name": "DACTOLISIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1879463", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["CARCINOMA", "NEOPLASM", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "ENDOMETRIAL NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "BRAIN NEOPLASM", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}], "max_phase": 3, "name": "DACOMITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110732", "mechanisms": ["Epidermal growth factor receptor inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": ["HEAD AND NECK SQUAMOUS CELL CARCINOMA", "SQUAMOUS CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "BRAIN NEOPLASM", "CARCINOMA", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLOBAZAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70418", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DRAVET SYNDROME", "NEUROPATHIC PAIN", "PAIN", "LENNOX-GASTAUT SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "PICK DISEASE", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "TOLCAPONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324", "mechanisms": ["Catechol O-methyltransferase inhibitor"], "genes": ["COMT"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "PARKINSON'S DISEASE", "GAMBLING BEHAVIOUR", "PICK DISEASE", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}], "max_phase": 4, "name": "TRASTUZUMAB EMTANSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743082", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Antibody", "diseases": ["BREAST CARCINOMA", "GASTRIC CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "NEOPLASM", "LYMPHOMA"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 4}, {"efo_term": "CONSTIPATION", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 2}], "max_phase": 4, "name": "LUBIPROSTONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201134", "mechanisms": ["Chloride channel protein 2 opener"], "genes": ["CLCN2"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "CONSTIPATION", "OPIOID DEPENDENCE", "COLORECTAL ADENOCARCINOMA", "HIV INFECTION"]}, {"indications": [{"efo_term": "NERVOUS SYSTEM DISEASE", "stage": 3}, {"efo_term": "TORTICOLLIS", "stage": 3}, {"efo_term": "SPASTICITY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "ABOBOTULINUMTOXINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108570", "mechanisms": ["Synaptosomal-associated protein 25 inhibitor"], "genes": ["SNAP25"], "type": "Unknown", "diseases": ["NERVOUS SYSTEM DISEASE", "OVERACTIVE BLADDER", "TORTICOLLIS", "PAIN", "SPASTICITY"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 4}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}], "max_phase": 4, "name": "BOSUTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "Tyrosine-protein kinase SRC inhibitor", "Tyrosine-protein kinase Lyn  inhibitor"], "genes": ["ABL1", "SRC", "LYN"], "type": "Small molecule", "diseases": ["GLIOBLASTOMA MULTIFORME", "NEOPLASM", "CHRONIC MYELOGENOUS LEUKEMIA", "BREAST NEOPLASM", "LEUKEMIA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "RECTUM CANCER", "stage": 1}], "max_phase": 3, "name": "MIDOSTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "LIVER DISEASE", "NEOPLASM", "RECTUM CANCER"]}, {"indications": [{"efo_term": "SCIATICA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 1}], "max_phase": 3, "name": "Fasinumab", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109528", "mechanisms": ["Beta-nerve growth factor inhibitor"], "genes": ["NGF"], "type": "Antibody", "diseases": ["SCIATICA", "OSTEOARTHRITIS", "PAIN", "OSTEOARTHRITIS, KNEE", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "BRAIN ANEURYSM", "stage": 1}], "max_phase": 4, "name": "NIMODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "DIAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "ANXIETY", "PAIN"]}, {"indications": [{"efo_term": "PANIC DISORDER", "stage": 4}, {"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}], "max_phase": 4, "name": "ALPRAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PANIC DISORDER", "ANXIETY", "POST-TRAUMATIC STRESS DISORDER", "ANXIETY DISORDER"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "ENTACAPONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL953", "mechanisms": ["Catechol O-methyltransferase inhibitor"], "genes": ["COMT"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "METAMPHETAMINE DEPENDENCE", "EPILEPSY", "OBESITY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}], "max_phase": 4, "name": "LISDEXAMFETAMINE DIMESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent", "Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3", "SLC18A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "EATING DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "TAPENTADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201777", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "VINORELBIN DITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL538943", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BREAST CARCINOMA", "LUNG CARCINOMA", "CANCER"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}], "max_phase": 3, "name": "DINACICLIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103840", "mechanisms": ["Cyclin-dependent kinase 5 inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["MELANOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "MULTIPLE MYELOMA", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}], "max_phase": 2, "name": "AZD-2014", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1078983", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["PROSTATE CARCINOMA", "CANCER", "GLIOBLASTOMA MULTIFORME", "CLEAR CELL RENAL CARCINOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 2}], "max_phase": 2, "name": "PH-797804", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088751", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OSTEOARTHRITIS", "GENICULATE HERPES ZOSTER"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "DEFACTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137331", "mechanisms": ["Protein tyrosine kinase 2 beta inhibitor"], "genes": ["PTK2B"], "type": "Small molecule", "diseases": ["LYMPHOMA", "CANCER", "NON-SMALL CELL LUNG CARCINOMA", "MALIGNANT PLEURAL MESOTHELIOMA"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "POSTERIOR UVEITIS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "SOTRASTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL565612", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["DIFFUSE LARGE B-CELL LYMPHOMA", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "PSORIASIS"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1C", "CACNG7", "CACNG2", "CACNG8", "CACNG5", "CACNG4"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "ANAL FISSURE", "stage": 2}], "max_phase": 4, "name": "NIFEDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ISRADIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CARDIOVASCULAR DISEASE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "ANAL FISSURE", "stage": 3}, {"efo_term": "CONSTIPATION", "stage": 1}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "DILTIAZEM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CONSTIPATION", "ANAL FISSURE", "SKIN DISEASE", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "INJURY", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "PENTOBARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HEART DISEASE", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLONAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "EPILEPSY", "MARIJUANA DEPENDENCE"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}], "max_phase": 4, "name": "METHOXYFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341", "mechanisms": ["GABA-A receptor; anion channel positive modulator", "Glycine receptor (alpha-1/beta) agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["FEVER", "PAIN", "CANCER"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "SELEGILINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "PARKINSON'S DISEASE", "BORDERLINE PERSONALITY DISORDER SYMPTOM"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "DESVENLAFAXINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1118", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "FIBROMYALGIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}], "max_phase": 4, "name": "DULOXETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200328", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "GASTROPARESIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 1}], "max_phase": 4, "name": "NORTRIPTYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201156", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["PSORIASIS", "ATOPIC ECZEMA", "GASTROPARESIS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}], "max_phase": 4, "name": "DESVENLAFAXINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201728", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 3, "name": "DASOTRALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301595", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4", "SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "EATING DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "INDIBULIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49642", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["CANCER", "BREAST CARCINOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 3}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 1}], "max_phase": 4, "name": "VINCRISTINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501867", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "MELANOMA", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "PROGRESSIVE SUPRANUCLEAR PALSY", "stage": 2}], "max_phase": 2, "name": "DAVUNETIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103826", "mechanisms": ["Tubulin stabiliser"], "genes": ["TUBB4A"], "type": "Protein", "diseases": ["SCHIZOPHRENIA", "COGNITIVE IMPAIRMENT", "PROGRESSIVE SUPRANUCLEAR PALSY"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}], "max_phase": 2, "name": "Selurampanel", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545042", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIA2", "GRIK4", "GRIA4", "GRIA1", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SEIZURES", "TINNITUS"]}, {"indications": [{"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}], "max_phase": 4, "name": "ESCITALOPRAM OXALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200322", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "ANXIETY DISORDER"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 4}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 2}], "max_phase": 4, "name": "TETRABENAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117785", "mechanisms": ["Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC18A2"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE", "TOURETTE SYNDROME", "MOVEMENT DISORDER"]}, {"indications": [{"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 4}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "PONATINIB HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105708", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "Bcr/Abl fusion protein inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["CANCER", "CHRONIC MYELOGENOUS LEUKEMIA", "ACUTE LYMPHOBLASTIC LEUKEMIA"]}, {"indications": [{"efo_term": "MANTLE CELL LYMPHOMA", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "AT-7519", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445813", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["MANTLE CELL LYMPHOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA"]}, {"indications": [{"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEUROBLASTOMA", "stage": 1}], "max_phase": 2, "name": "SF-1126", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2326966", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["CANCER", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "NEUROBLASTOMA"]}, {"indications": [{"efo_term": "DIARRHEA", "stage": 4}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CROFELEMER", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108184", "mechanisms": ["Cystic fibrosis transmembrane conductance regulator inhibitor"], "genes": ["CFTR"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "DIARRHEA", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "BMS-582949", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1230065", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["PSORIASIS", "VASCULAR DISEASE", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ACTINIC KERATOSIS", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 2, "name": "KX2-391", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571546", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["PROSTATE CARCINOMA", "ACUTE MYELOID LEUKEMIA", "ACTINIC KERATOSIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}], "max_phase": 1, "name": "AC-480", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1645462", "mechanisms": ["Receptor protein-tyrosine kinase erbB-4 inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM", "CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "Poziotinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545154", "mechanisms": ["Epidermal growth factor receptor inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "CANCER", "NEOPLASM"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "CLEVIDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCOLIOSIS", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERLIPIDEMIA", "stage": 3}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}], "max_phase": 4, "name": "PROBUCOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608", "mechanisms": ["ATP-binding cassette sub-family A member 1 inhibitor"], "genes": ["ABCA1"], "type": "Small molecule", "diseases": ["DIABETIC NEPHROPATHY", "HYPERLIPIDEMIA", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}], "max_phase": 4, "name": "FLUMAZENIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407", "mechanisms": ["GABA-A receptor; anion channel allosteric antagonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "ISOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "INGUINAL HERNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}], "max_phase": 4, "name": "ESZOPICLONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSTRUCTIVE SLEEP APNEA"]}, {"indications": [{"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}], "max_phase": 4, "name": "DESFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "SAFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL396778", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}], "max_phase": 4, "name": "RASAGILINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201142", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Monoamine oxidase B inhibitor", "Glutamate [NMDA] receptor antagonist"], "genes": ["MAOB", "GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "AMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "AMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "PHENTERMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1574", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["OBESITY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DESIPRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1696", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "METHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "CANCER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SACCHARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200992", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent", "Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3", "SLC18A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "MILNACIPRAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096626", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 3, "name": "EDIVOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103857", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544971", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent", "Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3", "SLC18A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 4, "name": "MAZINDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4", "SLC6A3"], "type": "Small molecule", "diseases": ["OBESITY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "COLORECTAL CANCER", "stage": 1}], "max_phase": 3, "name": "PACLITAXEL POLIGLUMEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108628", "mechanisms": ["Tubulin stabiliser "], "genes": ["TUBB4A"], "type": "Unknown", "diseases": ["NEOPLASM", "COLORECTAL CANCER"]}, {"indications": [{"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}], "max_phase": 2, "name": "SAGOPILONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2304041", "mechanisms": ["Tubulin stabiliser"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["GLIOBLASTOMA MULTIFORME", "BREAST NEOPLASM"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM", "stage": 2}], "max_phase": 4, "name": "CITALOPRAM HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200781", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "FARAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276138", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "MK-8777", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707401", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}], "max_phase": 2, "name": "AZD7325", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783282", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER", "ANXIETY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RESERPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772", "mechanisms": ["Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC18A2"], "type": "Small molecule", "diseases": ["HYPERTENSION", "PULMONARY HYPERTENSION"]}, {"indications": [{"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 2}], "max_phase": 3, "name": "VALBENAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364639", "mechanisms": ["Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC18A2"], "type": "Small molecule", "diseases": ["MOVEMENT DISORDER", "TOURETTE SYNDROME"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 2}], "max_phase": 4, "name": "METYROSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200862", "mechanisms": ["Tyrosine 3-hydroxylase inhibitor"], "genes": ["TH"], "type": "Small molecule", "diseases": ["HYPERTENSION", "PSYCHOSIS"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 2, "name": "BAFETINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206834", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "Tyrosine-protein kinase Lyn  inhibitor"], "genes": ["ABL1", "LYN"], "type": "Small molecule", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 4, "name": "NILOTINIB HYDROCHLORIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201740", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["CHRONIC MYELOGENOUS LEUKEMIA", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 2, "name": "SELICICLIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14762", "mechanisms": ["Cyclin-dependent kinase 5 inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "Roniciclib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544942", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["SMALL CELL LUNG CARCINOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}], "max_phase": 2, "name": "GEDATOLISIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592445", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["ENDOMETRIAL NEOPLASM", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "PF-04691502", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1234354", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["CANCER", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}], "max_phase": 1, "name": "OMIPALISIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1236962", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["NEOPLASM", "IDIOPATHIC PULMONARY FIBROSIS"]}, {"indications": [{"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "APITOLISIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1922094", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["NON-HODGKINS LYMPHOMA", "RENAL CELL CARCINOMA"]}, {"indications": [{"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "LY-3023414", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544999", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["NEOPLASM", "ENDOMETRIAL NEOPLASM"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 1}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 1}], "max_phase": 1, "name": "INK-128", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545056", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["LYMPHOMA", "HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "CYSTIC FIBROSIS", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 0}], "max_phase": 4, "name": "IVACAFTOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2010601", "mechanisms": ["Cystic fibrosis transmembrane conductance regulator positive modulator"], "genes": ["CFTR"], "type": "Small molecule", "diseases": ["CYSTIC FIBROSIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 2, "name": "QBW251", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545292", "mechanisms": ["Cystic fibrosis transmembrane conductance regulator activator"], "genes": ["CFTR"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "DROOLING", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 2}], "max_phase": 4, "name": "BOTULINUM TOXIN TYPE B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201569", "mechanisms": ["Vesicle-associated membrane protein 2 inhibitor"], "genes": ["VAMP2"], "type": "Unknown", "diseases": ["DROOLING", "HYPERHIDROSIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 2, "name": "AZD-7624", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9960", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "INFLAMMATION"]}, {"indications": [{"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "TALMAPIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL514201", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["MULTIPLE MYELOMA", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "PF-03715455", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1938400", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ACUTE LUNG INJURY", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "DILMAPIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103838", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE LUNG INJURY"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 3}], "max_phase": 3, "name": "SOLANEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743072", "mechanisms": ["Beta amyloid A4 protein other"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE", "COGNITIVE IMPAIRMENT"]}, {"indications": [{"efo_term": "CANCER", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "ILORASERTIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1980297", "mechanisms": ["SRC inhibitor"], "genes": ["FYN", "SRC", "LYN"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "BMS-690514", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545396", "mechanisms": ["Receptor protein-tyrosine kinase erbB-4 inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": ["CANCER", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 1}], "max_phase": 3, "name": "FULRANUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743023", "mechanisms": ["Beta-nerve growth factor inhibitor"], "genes": ["NGF"], "type": "Antibody", "diseases": ["PAIN", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1C", "CACNG7", "CACNG2", "CACNG8", "CACNG5", "CACNG4"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "NICARDIPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200326", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "INTRACEREBRAL HEMORRHAGE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "METHARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "CHLORDIAZEPOXIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "OXAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL568", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 3}], "max_phase": 4, "name": "ETOMIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "TEMAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL967", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "PRAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL969", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "HALAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "MEPROBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 3}], "max_phase": 4, "name": "MIDAZOLAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200420", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-06372865", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707402", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ADIPIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103791", "mechanisms": ["GABA-A receptor; benzodiazepine site partial agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "RESEQUINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107801", "mechanisms": ["GABA-A receptor; benzodiazepine site inverse agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 4, "name": "ZALEPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1521", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "ZOLPIDEM TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723343", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "SAFINAMIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48582", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "SELEGILINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200904", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["MARIJUANA DEPENDENCE"]}, {"indications": [{"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}], "max_phase": 4, "name": "PHENELZINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200895", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PROSTATE ADENOCARCINOMA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "ISOCARBOXAZID", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201168", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "DEXMETHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL904", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "FIBROMYALGIA", "stage": 3}], "max_phase": 3, "name": "ESREBOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180101", "mechanisms": [" Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["FIBROMYALGIA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "IMIPRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1692", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "ATOMOXETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1702", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "BRETYLIUM TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095292", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "COMMON COLD", "stage": 3}], "max_phase": 4, "name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200724", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["COMMON COLD"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}], "max_phase": 4, "name": "PHENTERMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200912", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMITRIPTYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200964", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Norepinephrine transporter inhibitor", "Glutamate [NMDA] receptor antagonist"], "genes": ["SLC6A2", "GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "BUPROPION HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201735", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4", "SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "LEVOMILNACIPRAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105732", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "DESVENLAFAXINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039565", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}], "max_phase": 4, "name": "SIBUTRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200765", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4", "SLC6A3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "METHAMPHETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4", "SLC6A3"], "type": "Small molecule", "diseases": ["METAMPHETAMINE DEPENDENCE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LIAFENSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364614", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4", "SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}], "max_phase": 2, "name": "VERUBULIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL492399", "mechanisms": ["Tubulin disrupting agent"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "MULTIPLE MYELOMA", "stage": 2}], "max_phase": 2, "name": "LEXIBULIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL552212", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["MULTIPLE MYELOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 3, "name": "PLINABULIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096380", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "CROLIBULIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103852", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "OVARIAN CARCINOMA", "stage": 2}], "max_phase": 2, "name": "FOSBRETABULIN TROMETHAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105643", "mechanisms": ["Tubulin disrupting agent"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": ["OVARIAN CARCINOMA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 2, "name": "TEZAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14935", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIA2", "GRIK4", "GRIA4", "GRIA1", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 3}], "max_phase": 4, "name": "FLUVOXAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1409", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "PAROXETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1708", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "SERTRALINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1709", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "MENOPAUSE", "stage": 3}], "max_phase": 4, "name": "PAROXETINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200609", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["MENOPAUSE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "CLOMIPRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200710", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}], "max_phase": 4, "name": "TRAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200798", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "FLUOXETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201082", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "VILAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615374", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 2, "name": "GSK163090", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1631540", "mechanisms": ["Serotonin transporter antagonist"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "VORTIOXETINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107387", "mechanisms": ["Serotonin transporter inhibitor"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PORTAL HYPERTENSION", "stage": 2}], "max_phase": 2, "name": "COBIPROSTONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103799", "mechanisms": ["Chloride channel protein 2 activator"], "genes": ["CLCN2"], "type": "Small molecule", "diseases": ["PORTAL HYPERTENSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "MIBAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1277001", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "PF-04958242", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707379", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 0, "name": "BIIB054", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833330", "mechanisms": ["Alpha-synuclein inhibitor"], "genes": ["SNCA"], "type": "Antibody", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RESCINNAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1668", "mechanisms": ["Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC18A2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "DESERPIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200515", "mechanisms": ["Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC18A2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "ETAZOLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL356388", "mechanisms": ["GABA receptor beta-3 subunit positive allosteric modulator"], "genes": ["GABRB3"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "GAUCHER DISEASE", "stage": 2}], "max_phase": 2, "name": "AFEGOSTAT TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105671", "mechanisms": ["Beta-glucocerebrosidase stabiliser "], "genes": ["GBA"], "type": "Small molecule", "diseases": ["GAUCHER DISEASE"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [{"efo_term": "MULTIPLE MYELOMA", "stage": 2}], "max_phase": 2, "name": "AT-9283", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495727", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["MULTIPLE MYELOMA"]}, {"indications": [{"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 1}], "max_phase": 2, "name": "REBASTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1738757", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["CHRONIC MYELOGENOUS LEUKEMIA"]}, {"indications": [{"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 1, "name": "KW-2449", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908397", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 1, "name": "XL-228", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545085", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "SRC inhibitor"], "genes": ["ABL1", "FYN", "SRC", "LYN"], "type": "Small molecule", "diseases": ["LYMPHOMA"]}, {"indications": [{"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 1, "name": "ABL-001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545115", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["LIVER DISEASE"]}, {"indications": [{"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}], "max_phase": 3, "name": "Flumatinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545413", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor"], "genes": ["ABL1"], "type": "Small molecule", "diseases": ["CHRONIC MYELOGENOUS LEUKEMIA"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "GSK-690693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494089", "mechanisms": ["cAMP-dependent protein kinase (PKA) inhibitor", "Protein kinase C (PKC) inhibitor"], "genes": ["PRKACG", "PRKACA", "PRKACB", "PRKCA"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "PHA-793887", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1230607", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 1, "name": "VS-5584", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079593", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["LYMPHOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "PKI-179", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1258517", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "OSI-027", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3120215", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["LYMPHOMA"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 1, "name": "DS-3078a", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544963", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["LYMPHOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "BGT-226", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545096", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "Panulisib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545322", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "CYSTIC FIBROSIS", "stage": 4}], "max_phase": 4, "name": "LUMACAFTOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103870", "mechanisms": ["Cystic fibrosis transmembrane conductance regulator stabiliser"], "genes": ["CFTR"], "type": "Small molecule", "diseases": ["CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 3, "name": "TEZACAFTOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544914", "mechanisms": ["Cystic fibrosis transmembrane conductance regulator positive modulator"], "genes": ["CFTR"], "type": "Small molecule", "diseases": ["CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "VX-745", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119385", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 2, "name": "SEMAPIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107779", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["CROHN'S DISEASE"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "LY-3007113", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544998", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 1}], "max_phase": 2, "name": "FX-005", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545216", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "PG-760564", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545398", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "CRENEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743004", "mechanisms": ["Beta amyloid A4 protein other"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "GANTENERUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743025", "mechanisms": ["Beta amyloid A4 protein other"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "PONEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743058", "mechanisms": ["Beta amyloid A4 protein other"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "BAPINEUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108576", "mechanisms": ["Beta amyloid A4 protein other"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "GSK-933776", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109300", "mechanisms": ["Beta amyloid A4 protein other"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "ADUCANUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039540", "mechanisms": ["Beta amyloid A4 protein other"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 0, "name": "BAN2401", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833321", "mechanisms": ["Beta amyloid A4 protein inhibitor"], "genes": ["APP"], "type": "Antibody", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 2}], "max_phase": 2, "name": "(7S)-HYDROXYL-STAUROSPORINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL574737", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["MELANOMA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}], "max_phase": 4, "name": "AFATINIB DIMALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105712", "mechanisms": ["Receptor protein-tyrosine kinase erbB-4 inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}], "max_phase": 4, "name": "OSIMERTINIB MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545063", "mechanisms": ["Epidermal growth factor receptor inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 2, "name": "SAR-407899", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545341", "mechanisms": ["Rho-associated protein kinase inhibitor"], "genes": ["ROCK1"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1C", "CACNG7", "CACNG2", "CACNG8", "CACNG5", "CACNG4"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "FELODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "NISOLDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 3, "name": "TEDISAMIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113461", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA4"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA4"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [], "max_phase": 3, "name": "INDIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL262075", "mechanisms": ["GABA receptor alpha-1 subunit positive allosteric modulator"], "genes": ["GABRA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTALBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETHCHLORVYNOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOPENTAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL738", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOHEXITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30219", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ESTAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOTHANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENTOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL971", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GLUTETHIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1102", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ENFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257", "mechanisms": ["GABA-A receptor; anion channel positive modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLURAZEPAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200602", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200703", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRICLOFOS SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200789", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYPRYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TALBUTAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SECOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200903", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTABARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200982", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIAMYLAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201065", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["GABA-A receptor; anion channel positive modulator", "Glutamate [NMDA] receptor antagonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GRIN2D", "GABRA4", "GABRG2", "GRIN3B", "GABRA6", "GABRB2", "GABRA2", "GRIN2C", "GABRG1", "GABRB1", "GABRB3", "GRIN1", "GABRG3", "GRIN2A", "GABRA5", "GABRD", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CLORAZEPATE DIPOTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096631", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "Lorediplon", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707317", "mechanisms": ["GABA-A receptor; benzodiazepine site positive allosteric modulator"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "GABOXADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312443", "mechanisms": ["GABA-A receptor; agonist GABA site agonist"], "genes": ["GABRA1", "GABRA4", "GABRA6", "GABRB2", "GABRA2", "GABRB1", "GABRB3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PARGYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200425", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRANYLCYPROMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218887", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GUANETHIDINE MONOSULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1345", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIETHYLPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTRIPTYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200332", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ASPARTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200377", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200387", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Norepinephrine transporter inhibitor", "Glutamate [NMDA] receptor antagonist"], "genes": ["SLC6A2", "GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENMETRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200483", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NEFAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200492", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GUANADREL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200594", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "IMIPRAMINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200631", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200695", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXTROAMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200782", "mechanisms": ["Norepinephrine transporter releasing agent", "Dopamine transporter releasing agent", "Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3", "SLC18A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PSEUDOEPHEDRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200900", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201535", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PSEUDOEPHEDRINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201483", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MAPROTILINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237135", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXEPIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628234", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENDIMETRAZINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1898523", "mechanisms": ["Norepinephrine transporter inhibitor", "Dopamine transporter inhibitor"], "genes": ["SLC6A2", "SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FAXELADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103829", "mechanisms": ["Norepinephrine transporter inhibitor", "Serotonin transporter inhibitor"], "genes": ["SLC6A2", "SLC6A4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETHANIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110368", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENZPHETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544906", "mechanisms": ["Norepinephrine transporter releasing agent", "Synaptic vesicular amine transporter inhibitor"], "genes": ["SLC6A2", "SLC18A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FOSBRETABULIN DISODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289351", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VINBLASTINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL378544", "mechanisms": ["Tubulin inhibitor"], "genes": ["TUBB4A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPHENTERMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200595", "mechanisms": ["Serotonin transporter substrate"], "genes": ["SLC6A4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ZONAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119625", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DASOLAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103869", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist", "Glutamate receptor ionotropic kainate 1 antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1", "GRIK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "BECAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107735", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CX1739", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707399", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD6280", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783256", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZM-475271", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545150", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "Tyrosine-protein kinase SRC inhibitor"], "genes": ["ABL1", "SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-0424", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545177", "mechanisms": ["Tyrosine-protein kinase ABL inhibitor", "Tyrosine-protein kinase SRC inhibitor"], "genes": ["ABL1", "SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "FORIGERIMOD ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105726", "mechanisms": ["Heat shock cognate 71 kDa protein inhibitor"], "genes": ["HSPA8"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RGB-286638", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545083", "mechanisms": ["Cyclin-dependent kinase 5 inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-5438", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488436", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-8055", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1801204", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Palomid-529", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2141712", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RG-7603", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2331680", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PWT-33587", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545006", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CC-223", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545151", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DS-7423", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545248", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PWT-33579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545323", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VOXTALISIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545366", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CC-115", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545426", "mechanisms": ["Serine/threonine-protein kinase mTOR inhibitor"], "genes": ["MTOR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DORAMAPIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103667", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RWJ-67657", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190333", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TAK-715", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL363648", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Ro-3201195", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL203567", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AMG-548", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL585902", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PAMAPIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090089", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VX-702", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090090", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ARRY-797", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088750", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SD-0006", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090173", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SCIO-323", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1614702", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "R-1487", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1766582", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-6703", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2031465", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RALIMETINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364626", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SC-80036", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544930", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GSK-610677", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544968", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LEO-15520", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545074", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AVE-9940", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545117", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PS-516895", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545139", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TA-5493", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545201", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Acumapimod", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545226", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "KC-706", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545282", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Pexmetinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545297", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SB-85635", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545384", "mechanisms": ["MAP kinase p38 alpha inhibitor"], "genes": ["MAPK14"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "JNJ-26483327", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545133", "mechanisms": ["Tyrosine-protein kinase FYN inhibitor", "Tyrosine-protein kinase SRC inhibitor", "Receptor protein-tyrosine kinase erbB-4 inhibitor", "Tyrosine-protein kinase Lyn  inhibitor"], "genes": ["FYN", "SRC", "ERBB4", "LYN"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ENMD-981693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52885", "mechanisms": ["SRC inhibitor"], "genes": ["FYN", "SRC", "LYN"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TG100-801", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403989", "mechanisms": ["SRC inhibitor"], "genes": ["FYN", "SRC", "LYN"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CEP-2563", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545332", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PD-0166285", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545196", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "CANERTINIB DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545315", "mechanisms": ["Receptor protein-tyrosine kinase erbB-4 inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "DACOMITINIB HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105719", "mechanisms": ["Receptor protein-tyrosine kinase erbB-4 inhibitor"], "genes": ["ERBB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Y-39983", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571948", "mechanisms": ["Rho-associated protein kinase inhibitor"], "genes": ["ROCK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AT-13148", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544960", "mechanisms": ["Rho-associated protein kinase inhibitor"], "genes": ["ROCK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VEROSUDIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545065", "mechanisms": ["Rho-associated protein kinase inhibitor"], "genes": ["ROCK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMA0076", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545073", "mechanisms": ["Rho-associated protein kinase inhibitor"], "genes": ["ROCK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DE-104", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545153", "mechanisms": ["Rho-associated protein kinase inhibitor"], "genes": ["ROCK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNG3", "CACNA1C", "CACNG7", "CACNG2", "CACNG8", "CACNG5", "CACNG4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VERAPAMIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DILTIAZEM MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200805", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMLODIPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200984", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GUANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200728", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNA4"], "type": "Small molecule", "diseases": []}], "heat": 0.23800614687074598, "nodes": [{"assoc": 0.03313, "id": "ENSG00000005893", "label": "LAMP2"}, {"assoc": 1.0, "id": "ENSG00000022355", "label": "GABRA1"}, {"assoc": 0.516577168712, "id": "ENSG00000064692", "label": "SNCAIP"}, {"assoc": 1.0, "id": "ENSG00000069535", "label": "MAOB"}, {"assoc": 0.699023262144, "id": "ENSG00000073969", "label": "NSF"}, {"assoc": 0.0545640218523, "id": "ENSG00000074317", "label": "SNCB"}, {"assoc": 1.0, "id": "ENSG00000093010", "label": "COMT"}, {"assoc": 1.0, "id": "ENSG00000094755", "label": "GABRP"}, {"assoc": 1.0, "id": "ENSG00000100225", "label": "FBXO7"}, {"assoc": 0.036432, "id": "ENSG00000100505", "label": "TRIM9"}, {"assoc": 1.0, "id": "ENSG00000102287", "label": "GABRE"}, {"assoc": 1.0, "id": "ENSG00000103546", "label": "SLC6A2"}, {"assoc": 1.0, "id": "ENSG00000104833", "label": "TUBB4A"}, {"assoc": 1.0, "id": "ENSG00000105464", "label": "GRIN2D"}, {"assoc": 0.2, "id": "ENSG00000105737", "label": "GRIK5"}, {"assoc": 0.655178950817, "id": "ENSG00000107295", "label": "SH3GL2"}, {"assoc": 0.0631004131272, "id": "ENSG00000107859", "label": "PITX3"}, {"assoc": 0.0438370088889, "id": "ENSG00000108387", "label": "38231"}, {"assoc": 0.977475831931, "id": "ENSG00000108576", "label": "SLC6A4"}, {"assoc": 1.0, "id": "ENSG00000109158", "label": "GABRA4"}, {"assoc": 0.256004491525, "id": "ENSG00000109738", "label": "GLRB"}, {"assoc": 0.0315322200539, "id": "ENSG00000112530", "label": "PACRG"}, {"assoc": 1.0, "id": "ENSG00000113327", "label": "GABRG2"}, {"assoc": 1.0, "id": "ENSG00000114859", "label": "CLCN2"}, {"assoc": 1.0, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 1.0, "id": "ENSG00000116288", "label": "PARK7"}, {"assoc": 1.0, "id": "ENSG00000120251", "label": "GRIA2"}, {"assoc": 0.0631284527935, "id": "ENSG00000123454", "label": "DBH"}, {"assoc": 0.0811, "id": "ENSG00000126432", "label": "PRDX5"}, {"assoc": 0.0661991421018, "id": "ENSG00000131095", "label": "GFAP"}, {"assoc": 1.0, "id": "ENSG00000132437", "label": "DDC"}, {"assoc": 1.0, "id": "ENSG00000132639", "label": "SNAP25"}, {"assoc": 0.0462128898299, "id": "ENSG00000132718", "label": "SYT11"}, {"assoc": 0.041976, "id": "ENSG00000141744", "label": "PNMT"}, {"assoc": 1.0, "id": "ENSG00000142319", "label": "SLC6A3"}, {"assoc": 1.0, "id": "ENSG00000145335", "label": "SNCA"}, {"assoc": 1.0, "id": "ENSG00000145863", "label": "GABRA6"}, {"assoc": 1.0, "id": "ENSG00000145864", "label": "GABRB2"}, {"assoc": 0.2, "id": "ENSG00000149403", "label": "GRIK4"}, {"assoc": 0.0464504055556, "id": "ENSG00000150540", "label": "HNMT"}, {"assoc": 0.47445175694, "id": "ENSG00000150672", "label": "DLG2"}, {"assoc": 1.0, "id": "ENSG00000151834", "label": "GABRA2"}, {"assoc": 1.0, "id": "ENSG00000152578", "label": "GRIA4"}, {"assoc": 0.0495816342908, "id": "ENSG00000154237", "label": "LRRK1"}, {"assoc": 0.15474721767, "id": "ENSG00000154277", "label": "UCHL1"}, {"assoc": 1.0, "id": "ENSG00000155511", "label": "GRIA1"}, {"assoc": 1.0, "id": "ENSG00000158828", "label": "PINK1"}, {"assoc": 1.0, "id": "ENSG00000159082", "label": "SYNJ1"}, {"assoc": 0.218132481702, "id": "ENSG00000160307", "label": "S100B"}, {"assoc": 1.0, "id": "ENSG00000161509", "label": "GRIN2C"}, {"assoc": 1.0, "id": "ENSG00000163285", "label": "GABRG1"}, {"assoc": 1.0, "id": "ENSG00000163288", "label": "GABRB1"}, {"assoc": 0.2, "id": "ENSG00000163873", "label": "GRIK3"}, {"assoc": 0.2, "id": "ENSG00000164418", "label": "GRIK2"}, {"assoc": 0.0777363418807, "id": "ENSG00000165646", "label": "SLC18A2"}, {"assoc": 1.0, "id": "ENSG00000166206", "label": "GABRB3"}, {"assoc": 0.0485061031825, "id": "ENSG00000167755", "label": "KLK6"}, {"assoc": 0.0655981748647, "id": "ENSG00000170775", "label": "GPR37"}, {"assoc": 0.2, "id": "ENSG00000171189", "label": "GRIK1"}, {"assoc": 0.0513721749252, "id": "ENSG00000171368", "label": "TPPP"}, {"assoc": 0.0459570302948, "id": "ENSG00000175193", "label": "PARL"}, {"assoc": 1.0, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000177628", "label": "GBA"}, {"assoc": 1.0, "id": "ENSG00000180176", "label": "TH"}, {"assoc": 0.0380046388889, "id": "ENSG00000181220", "label": "ZNF746"}, {"assoc": 1.0, "id": "ENSG00000182256", "label": "GABRG3"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 1.0, "id": "ENSG00000185345", "label": "PRKN"}, {"assoc": 1.0, "id": "ENSG00000186297", "label": "GABRA5"}, {"assoc": 0.89605007108, "id": "ENSG00000186868", "label": "MAPT"}, {"assoc": 1.0, "id": "ENSG00000187730", "label": "GABRD"}, {"assoc": 1.0, "id": "ENSG00000188906", "label": "LRRK2"}, {"assoc": 0.1860031923, "id": "ENSG00000198722", "label": "UNC13B"}, {"assoc": 1.0, "id": "ENSG00000198785", "label": "GRIN3A"}, {"assoc": 0.107154003056, "id": "ENSG00000204842", "label": "ATXN2"}, {"assoc": 0, "id": "ENSG00000097007", "label": "ABL1"}, {"assoc": 0, "id": "ENSG00000150991", "label": "UBC"}, {"assoc": 0, "id": "ENSG00000165059", "label": "PRKACG"}, {"assoc": 0, "id": "ENSG00000150995", "label": "ITPR1"}, {"assoc": 0, "id": "ENSG00000072062", "label": "PRKACA"}, {"assoc": 0, "id": "ENSG00000178372", "label": "CALML5"}, {"assoc": 0, "id": "ENSG00000169885", "label": "CALML6"}, {"assoc": 0, "id": "ENSG00000183943", "label": "PRKX"}, {"assoc": 0, "id": "ENSG00000178363", "label": "CALML3"}, {"assoc": 0, "id": "ENSG00000142875", "label": "PRKACB"}, {"assoc": 0, "id": "ENSG00000198668", "label": "CALM1"}, {"assoc": 0, "id": "ENSG00000089250", "label": "NOS1"}, {"assoc": 0, "id": "ENSG00000174775", "label": "HRAS"}, {"assoc": 0, "id": "ENSG00000254647", "label": "INS"}, {"assoc": 0, "id": "ENSG00000186298", "label": "PPP1CC"}, {"assoc": 0, "id": "ENSG00000172531", "label": "PPP1CA"}, {"assoc": 0, "id": "ENSG00000109971", "label": "HSPA8"}, {"assoc": 0, "id": "ENSG00000100151", "label": "PICK1"}, {"assoc": 0, "id": "ENSG00000164885", "label": "CDK5"}, {"assoc": 0, "id": "ENSG00000070808", "label": "CAMK2A"}, {"assoc": 0, "id": "ENSG00000197943", "label": "PLCG2"}, {"assoc": 0, "id": "ENSG00000148660", "label": "CAMK2G"}, {"assoc": 0, "id": "ENSG00000058404", "label": "CAMK2B"}, {"assoc": 0, "id": "ENSG00000145349", "label": "CAMK2D"}, {"assoc": 0, "id": "ENSG00000213639", "label": "PPP1CB"}, {"assoc": 0, "id": "ENSG00000107758", "label": "PPP3CB"}, {"assoc": 0, "id": "ENSG00000077522", "label": "ACTN2"}, {"assoc": 0, "id": "ENSG00000138798", "label": "EGF"}, {"assoc": 0, "id": "ENSG00000127914", "label": "AKAP9"}, {"assoc": 0, "id": "ENSG00000112640", "label": "PPP2R5D"}, {"assoc": 0, "id": "ENSG00000139112", "label": "GABARAPL1"}, {"assoc": 0, "id": "ENSG00000161011", "label": "SQSTM1"}, {"assoc": 0, "id": "ENSG00000170296", "label": "GABARAP"}, {"assoc": 0, "id": "ENSG00000034713", "label": "GABARAPL2"}, {"assoc": 0, "id": "ENSG00000115993", "label": "TRAK2"}, {"assoc": 0, "id": "ENSG00000147162", "label": "OGT"}, {"assoc": 0, "id": "ENSG00000166167", "label": "BTRC"}, {"assoc": 0, "id": "ENSG00000171723", "label": "GPHN"}, {"assoc": 0, "id": "ENSG00000198793", "label": "MTOR"}, {"assoc": 0, "id": "ENSG00000100644", "label": "HIF1A"}, {"assoc": 0, "id": "ENSG00000075711", "label": "DLG1"}, {"assoc": 0, "id": "ENSG00000082458", "label": "DLG3"}, {"assoc": 0, "id": "ENSG00000152208", "label": "GRID2"}, {"assoc": 0, "id": "ENSG00000047932", "label": "GOPC"}, {"assoc": 0, "id": "ENSG00000135823", "label": "STX6"}, {"assoc": 0, "id": "ENSG00000149782", "label": "PLCB3"}, {"assoc": 0, "id": "ENSG00000123104", "label": "ITPR2"}, {"assoc": 0, "id": "ENSG00000106976", "label": "DNM1"}, {"assoc": 0, "id": "ENSG00000001626", "label": "CFTR"}, {"assoc": 0, "id": "ENSG00000100568", "label": "VTI1B"}, {"assoc": 0, "id": "ENSG00000170310", "label": "STX8"}, {"assoc": 0, "id": "ENSG00000117758", "label": "STX12"}, {"assoc": 0, "id": "ENSG00000079950", "label": "STX7"}, {"assoc": 0, "id": "ENSG00000106089", "label": "STX1A"}, {"assoc": 0, "id": "ENSG00000162236", "label": "STX5"}, {"assoc": 0, "id": "ENSG00000103496", "label": "STX4"}, {"assoc": 0, "id": "ENSG00000099940", "label": "SNAP29"}, {"assoc": 0, "id": "ENSG00000105402", "label": "NAPA"}, {"assoc": 0, "id": "ENSG00000108587", "label": "GOSR1"}, {"assoc": 0, "id": "ENSG00000196961", "label": "AP2A1"}, {"assoc": 0, "id": "ENSG00000101558", "label": "VAPA"}, {"assoc": 0, "id": "ENSG00000220205", "label": "VAMP2"}, {"assoc": 0, "id": "ENSG00000092108", "label": "SCFD1"}, {"assoc": 0, "id": "ENSG00000092531", "label": "SNAP23"}, {"assoc": 0, "id": "ENSG00000102189", "label": "EEA1"}, {"assoc": 0, "id": "ENSG00000112062", "label": "MAPK14"}, {"assoc": 0, "id": "ENSG00000105393", "label": "BABAM1"}, {"assoc": 0, "id": "ENSG00000135018", "label": "UBQLN1"}, {"assoc": 0, "id": "ENSG00000142192", "label": "APP"}, {"assoc": 0, "id": "ENSG00000010810", "label": "FYN"}, {"assoc": 0, "id": "ENSG00000120899", "label": "PTK2B"}, {"assoc": 0, "id": "ENSG00000154229", "label": "PRKCA"}, {"assoc": 0, "id": "ENSG00000197122", "label": "SRC"}, {"assoc": 0, "id": "ENSG00000123384", "label": "LRP1"}, {"assoc": 0, "id": "ENSG00000189056", "label": "RELN"}, {"assoc": 0, "id": "ENSG00000131711", "label": "MAP1B"}, {"assoc": 0, "id": "ENSG00000157193", "label": "LRP8"}, {"assoc": 0, "id": "ENSG00000178568", "label": "ERBB4"}, {"assoc": 0, "id": "ENSG00000113319", "label": "RASGRF2"}, {"assoc": 0, "id": "ENSG00000067900", "label": "ROCK1"}, {"assoc": 0, "id": "ENSG00000058335", "label": "RASGRF1"}, {"assoc": 0, "id": "ENSG00000134259", "label": "NGF"}, {"assoc": 0, "id": "ENSG00000006116", "label": "CACNG3"}, {"assoc": 0, "id": "ENSG00000151067", "label": "CACNA1C"}, {"assoc": 0, "id": "ENSG00000079841", "label": "RIMS1"}, {"assoc": 0, "id": "ENSG00000105605", "label": "CACNG7"}, {"assoc": 0, "id": "ENSG00000166862", "label": "CACNG2"}, {"assoc": 0, "id": "ENSG00000142408", "label": "CACNG8"}, {"assoc": 0, "id": "ENSG00000075429", "label": "CACNG5"}, {"assoc": 0, "id": "ENSG00000075461", "label": "CACNG4"}, {"assoc": 0, "id": "ENSG00000168036", "label": "CTNNB1"}, {"assoc": 0, "id": "ENSG00000198561", "label": "CTNND1"}, {"assoc": 0, "id": "ENSG00000044115", "label": "CTNNA1"}, {"assoc": 0, "id": "ENSG00000254087", "label": "LYN"}, {"assoc": 0, "id": "ENSG00000130522", "label": "JUND"}, {"assoc": 0, "id": "ENSG00000170558", "label": "CDH2"}, {"assoc": 0, "id": "ENSG00000170759", "label": "KIF5B"}, {"assoc": 0, "id": "ENSG00000125740", "label": "FOSB"}, {"assoc": 0, "id": "ENSG00000155974", "label": "GRIP1"}, {"assoc": 0, "id": "ENSG00000100393", "label": "EP300"}, {"assoc": 0, "id": "ENSG00000182979", "label": "MTA1"}, {"assoc": 0, "id": "ENSG00000147044", "label": "CASK"}, {"assoc": 0, "id": "ENSG00000137575", "label": "SDCBP"}, {"assoc": 0, "id": "ENSG00000152413", "label": "HOMER1"}, {"assoc": 0, "id": "ENSG00000104863", "label": "LIN7B"}, {"assoc": 0, "id": "ENSG00000165029", "label": "ABCA1"}, {"assoc": 0, "id": "ENSG00000054523", "label": "KIF1B"}, {"assoc": 0, "id": "ENSG00000157087", "label": "ATP2B2"}, {"assoc": 0, "id": "ENSG00000131899", "label": "LLGL1"}, {"assoc": 0, "id": "ENSG00000182255", "label": "KCNA4"}, {"assoc": 0, "id": "ENSG00000166963", "label": "MAP1A"}, {"assoc": 0, "id": "ENSG00000140941", "label": "MAP1LC3B"}, {"assoc": 0, "id": "ENSG00000170579", "label": "DLGAP1"}, {"assoc": 0, "id": "ENSG00000088986", "label": "DYNLL1"}, {"assoc": 0, "id": "ENSG00000088367", "label": "EPB41L1"}, {"assoc": 0, "id": "ENSG00000136295", "label": "TTYH3"}, {"assoc": 0, "id": "ENSG00000188037", "label": "CLCN1"}, {"assoc": 0, "id": "ENSG00000186469", "label": "GNG2"}, {"assoc": 0, "id": "ENSG00000182621", "label": "PLCB1"}, {"assoc": 0, "id": "ENSG00000137841", "label": "PLCB2"}, {"assoc": 0, "id": "ENSG00000069869", "label": "NEDD4"}, {"assoc": 0, "id": "ENSG00000185359", "label": "HGS"}, {"assoc": 0, "id": "ENSG00000197694", "label": "SPTAN1"}], "size": 198}, {"diseases": ["UNIPOLAR DEPRESSION", "PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS", "CARDIOVASCULAR DISEASE", "BIPOLAR DISORDER", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER", "ACUTE MYELOID LEUKEMIA", "NEONATAL ABSTINENCE SYNDROME", "EATING DISORDER", "HUNTINGTON DISEASE", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA", "ASTHMA", "NICOTINE DEPENDENCE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN", "FIBROMYALGIA", "PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME", "TYPE II DIABETES MELLITUS", "INFERTILITY", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY", "HEROIN DEPENDENCE", "PAIN", "OPIOID DEPENDENCE", "OSTEOARTHRITIS", "DRUG DEPENDENCE", "COCAINE DEPENDENCE", "LUMBAR DISC DEGENERATION", "CONSTIPATION", "EPILEPSY", "PRURITUS", "OBESITY", "CHRONIC KIDNEY DISEASE", "LIVER DISEASE", "ALCOHOL DRINKING", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "OBSESSIVE-COMPULSIVE DISORDER", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "COUGH", "OSTEOARTHRITIS, KNEE", "DIABETIC NEUROPATHY", "NARCOLEPSY WITH CATAPLEXY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "ALZHEIMERS DISEASE", "COGNITIVE IMPAIRMENT", "ALLERGIC RHINITIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "OTITIS MEDIA", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "IMMUNE SYSTEM DISEASE", "OCCLUSIVE ARTERIAL DISEASE", "KIDNEY STONE", "DYSPNEA", "DIGESTIVE SYSTEM DISEASE", "DIARRHEA", "SCOLIOSIS", "PREMATURE EJACULATION", "HALLUX VALGUS", "IRRITABLE BOWEL SYNDROME", "INSOMNIA", "INJURY", "POST-TRAUMATIC STRESS DISORDER", "MIGRAINE DISORDER", "NAUSEA AND VOMITING", "MENTAL OR BEHAVIOURAL DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "SCHIZOAFFECTIVE DISORDER", "PSORIASIS", "OVARIAN HYPERSTIMULATION SYNDROME", "ENDOMETRIOSIS", "PREECLAMPSIA", "HYPERTENSION", "GLAUCOMA", "SEPTIC SHOCK", "ANXIETY", "CEREBRAL ISCHEMIA", "SPASTICITY", "BONE NEOPLASM", "OPEN-ANGLE GLAUCOMA", "RETINITIS PIGMENTOSA", "HYPEREMIA", "OCULAR HYPERTENSION", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "AGE-RELATED MACULAR DEGENERATION", "ALLERGIC CONJUNCTIVITIS", "EYE DISEASE", "RHINITIS", "GRAVES OPHTHALMOPATHY", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "RENAL INSUFFICIENCY", "ORTHOSTATIC HYPOTENSION", "MULTIPLE SYSTEM ATROPHY", "STROKE", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "ATRIAL FIBRILLATION", "ANGINA PECTORIS", "CORONARY ARTERY DISEASE", "NEOPLASM", "MYOCARDIAL INFARCTION", "CHRONIC LYMPHOCYTIC LEUKEMIA", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "AMBLYOPIA", "PREMATURE BIRTH", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "TEMPORAL LOBE EPILEPSY", "SEXUAL DYSFUNCTION", "ANXIETY DISORDER", "NEUROGENIC BLADDER", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "HYPOGLYCEMIA", "MYOPIA", "PEPTIC ULCER"], "links": [{"source": "ENSG00000069696", "target": "ENSG00000082556"}, {"source": "ENSG00000069696", "target": "ENSG00000101180"}, {"source": "ENSG00000069696", "target": "ENSG00000112038"}, {"source": "ENSG00000069696", "target": "ENSG00000116329"}, {"source": "ENSG00000069696", "target": "ENSG00000134640"}, {"source": "ENSG00000069696", "target": "ENSG00000149295"}, {"source": "ENSG00000069696", "target": "ENSG00000150594"}, {"source": "ENSG00000069696", "target": "ENSG00000151577"}, {"source": "ENSG00000069696", "target": "ENSG00000163485"}, {"source": "ENSG00000069696", "target": "ENSG00000168412"}, {"source": "ENSG00000069696", "target": "ENSG00000178394"}, {"source": "ENSG00000069696", "target": "ENSG00000181072"}, {"source": "ENSG00000069696", "target": "ENSG00000184160"}, {"source": "ENSG00000082556", "target": "ENSG00000101180"}, {"source": "ENSG00000082556", "target": "ENSG00000112038"}, {"source": "ENSG00000082556", "target": "ENSG00000116329"}, {"source": "ENSG00000082556", "target": "ENSG00000134640"}, {"source": "ENSG00000082556", "target": "ENSG00000149295"}, {"source": "ENSG00000082556", "target": "ENSG00000150594"}, {"source": "ENSG00000082556", "target": "ENSG00000151577"}, {"source": "ENSG00000082556", "target": "ENSG00000163485"}, {"source": "ENSG00000082556", "target": "ENSG00000168412"}, {"source": "ENSG00000082556", "target": "ENSG00000178394"}, {"source": "ENSG00000082556", "target": "ENSG00000181072"}, {"source": "ENSG00000082556", "target": "ENSG00000184160"}, {"source": "ENSG00000101180", "target": "ENSG00000112038"}, {"source": "ENSG00000101180", "target": "ENSG00000116329"}, {"source": "ENSG00000101180", "target": "ENSG00000134640"}, {"source": "ENSG00000101180", "target": "ENSG00000149295"}, {"source": "ENSG00000101180", "target": "ENSG00000150594"}, {"source": "ENSG00000101180", "target": "ENSG00000151577"}, {"source": "ENSG00000101180", "target": "ENSG00000163485"}, {"source": "ENSG00000101180", "target": "ENSG00000168412"}, {"source": "ENSG00000101180", "target": "ENSG00000178394"}, {"source": "ENSG00000101180", "target": "ENSG00000181072"}, {"source": "ENSG00000101180", "target": "ENSG00000184160"}, {"source": "ENSG00000112038", "target": "ENSG00000116329"}, {"source": "ENSG00000112038", "target": "ENSG00000134640"}, {"source": "ENSG00000112038", "target": "ENSG00000149295"}, {"source": "ENSG00000112038", "target": "ENSG00000150594"}, {"source": "ENSG00000112038", "target": "ENSG00000151577"}, {"source": "ENSG00000112038", "target": "ENSG00000163485"}, {"source": "ENSG00000112038", "target": "ENSG00000168412"}, {"source": "ENSG00000112038", "target": "ENSG00000178394"}, {"source": "ENSG00000112038", "target": "ENSG00000181072"}, {"source": "ENSG00000112038", "target": "ENSG00000184160"}, {"source": "ENSG00000116329", "target": "ENSG00000134640"}, {"source": "ENSG00000116329", "target": "ENSG00000149295"}, {"source": "ENSG00000116329", "target": "ENSG00000150594"}, {"source": "ENSG00000116329", "target": "ENSG00000151577"}, {"source": "ENSG00000116329", "target": "ENSG00000163485"}, {"source": "ENSG00000116329", "target": "ENSG00000168412"}, {"source": "ENSG00000116329", "target": "ENSG00000178394"}, {"source": "ENSG00000116329", "target": "ENSG00000181072"}, {"source": "ENSG00000116329", "target": "ENSG00000184160"}, {"source": "ENSG00000134640", "target": "ENSG00000149295"}, {"source": "ENSG00000134640", "target": "ENSG00000150594"}, {"source": "ENSG00000134640", "target": "ENSG00000151577"}, {"source": "ENSG00000134640", "target": "ENSG00000163485"}, {"source": "ENSG00000134640", "target": "ENSG00000168412"}, {"source": "ENSG00000134640", "target": "ENSG00000178394"}, {"source": "ENSG00000134640", "target": "ENSG00000181072"}, {"source": "ENSG00000134640", "target": "ENSG00000184160"}, {"source": "ENSG00000149295", "target": "ENSG00000150594"}, {"source": "ENSG00000149295", "target": "ENSG00000151577"}, {"source": "ENSG00000149295", "target": "ENSG00000163485"}, {"source": "ENSG00000149295", "target": "ENSG00000168412"}, {"source": "ENSG00000149295", "target": "ENSG00000178394"}, {"source": "ENSG00000149295", "target": "ENSG00000181072"}, {"source": "ENSG00000149295", "target": "ENSG00000184160"}, {"source": "ENSG00000150594", "target": "ENSG00000151577"}, {"source": "ENSG00000150594", "target": "ENSG00000163485"}, {"source": "ENSG00000150594", "target": "ENSG00000168412"}, {"source": "ENSG00000150594", "target": "ENSG00000178394"}, {"source": "ENSG00000150594", "target": "ENSG00000181072"}, {"source": "ENSG00000150594", "target": "ENSG00000184160"}, {"source": "ENSG00000151577", "target": "ENSG00000163485"}, {"source": "ENSG00000151577", "target": "ENSG00000168412"}, {"source": "ENSG00000151577", "target": "ENSG00000178394"}, {"source": "ENSG00000151577", "target": "ENSG00000181072"}, {"source": "ENSG00000151577", "target": "ENSG00000184160"}, {"source": "ENSG00000163485", "target": "ENSG00000168412"}, {"source": "ENSG00000163485", "target": "ENSG00000178394"}, {"source": "ENSG00000163485", "target": "ENSG00000181072"}, {"source": "ENSG00000163485", "target": "ENSG00000184160"}, {"source": "ENSG00000168412", "target": "ENSG00000178394"}, {"source": "ENSG00000168412", "target": "ENSG00000181072"}, {"source": "ENSG00000168412", "target": "ENSG00000184160"}, {"source": "ENSG00000178394", "target": "ENSG00000181072"}, {"source": "ENSG00000178394", "target": "ENSG00000184160"}, {"source": "ENSG00000181072", "target": "ENSG00000184160"}], "drugs": [{"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "HAIR-PULLING", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 4, "name": "NALTREXONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "GAMBLING BEHAVIOUR", "OPIOID DEPENDENCE", "ALCOHOL DRINKING", "HIV INFECTION", "OBESITY", "PAIN", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "HEROIN DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "NICOTINE DEPENDENCE", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "COCAINE DEPENDENCE", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Dopamine D2 receptor partial agonist", "Serotonin 1a (5-HT1a) receptor partial agonist"], "genes": ["DRD2", "HTR1A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 4}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 2}, {"efo_term": "CONSTIPATION", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "BUPRENORPHINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["HEROIN DEPENDENCE", "PAIN", "OPIOID DEPENDENCE", "NEONATAL ABSTINENCE SYNDROME", "OSTEOARTHRITIS", "UNIPOLAR DEPRESSION", "DRUG DEPENDENCE", "HIV INFECTION", "COCAINE DEPENDENCE", "LUMBAR DISC DEGENERATION", "CONSTIPATION", "EPILEPSY", "EATING DISORDER", "PRURITUS", "OBESITY"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "SEPTIC SHOCK", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 1}], "max_phase": 4, "name": "CLONIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "GLAUCOMA", "HYPERTENSION", "PAIN", "CARDIOVASCULAR DISEASE", "MIGRAINE DISORDER", "NEONATAL ABSTINENCE SYNDROME", "SEPTIC SHOCK", "ANXIETY", "OPIOID DEPENDENCE", "MARIJUANA DEPENDENCE", "AUTISM SPECTRUM DISORDER", "CEREBRAL ISCHEMIA", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ADENOMA", "stage": 3}, {"efo_term": "MORBID OBESITY", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "OCCLUSIVE ARTERIAL DISEASE", "stage": 3}, {"efo_term": "OTITIS MEDIA", "stage": 2}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 1}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "FENTANYL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CANCER", "OTITIS MEDIA", "PAIN", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "IMMUNE SYSTEM DISEASE", "OPIOID DEPENDENCE", "OCCLUSIVE ARTERIAL DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PARKINSON'S DISEASE", "DIABETIC NEUROPATHY", "KIDNEY STONE", "PRURITUS", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "OVARIAN HYPERSTIMULATION SYNDROME", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 4, "name": "CABERGOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087", "mechanisms": ["Dopamine D2 receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "COCAINE DEPENDENCE", "BREAST CARCINOMA", "OBESITY", "ENDOMETRIOSIS"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "ROSACEA", "stage": 4}, {"efo_term": "INCREASED INTRAOCULAR PRESSURE", "stage": 4}, {"efo_term": "HYPEREMIA", "stage": 3}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "RETINITIS PIGMENTOSA", "stage": 1}], "max_phase": 4, "name": "BRIMONIDINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062257", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "RETINITIS PIGMENTOSA", "HYPEREMIA", "OCULAR HYPERTENSION", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "AGE-RELATED MACULAR DEGENERATION", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "INFERTILITY", "stage": 4}, {"efo_term": "HYPERPROLACTINEMIA", "stage": 4}, {"efo_term": "HYPOGONADISM", "stage": 4}, {"efo_term": "GROWTH HORMONE EXCESS", "stage": 4}, {"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "BROMOCRIPTINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200503", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "INFERTILITY", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Dopamine D2 receptor partial agonist", "Serotonin 1a (5-HT1a) receptor partial agonist"], "genes": ["DRD2", "HTR1A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "NEUROGENIC BLADDER", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 3}, {"efo_term": "URINARY INCONTINENCE", "stage": 3}, {"efo_term": "ENURESIS NOCTURNA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "OXYBUTYNIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1231", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "SEASONAL ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}, {"efo_term": "AMBLYOPIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MYOPIA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}, {"efo_term": "HYPOGLYCEMIA", "stage": 0}], "max_phase": 4, "name": "ATROPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["AMBLYOPIA", "SEASONAL ALLERGIC RHINITIS", "PAIN", "DIGESTIVE SYSTEM DISEASE", "HYPOGLYCEMIA", "MYOPIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "HALLUX VALGUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}], "max_phase": 4, "name": "MORPHINE SULFATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103744", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["NEONATAL ABSTINENCE SYNDROME", "PAIN", "HALLUX VALGUS", "PRURITUS", "OSTEOARTHRITIS, KNEE"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "HYDROCODONE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062267", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "PAIN", "LIVER DISEASE", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "TOURETTE SYNDROME", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "PF-03654746", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2151197", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "ALZHEIMERS DISEASE", "TOURETTE SYNDROME"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 2, "name": "GSK239512", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3092650", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "TAPENTADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201777", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "NAUSEA AND VOMITING", "stage": 2}], "max_phase": 4, "name": "PROCHLORPERAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "NAUSEA AND VOMITING", "PSYCHOSIS", "PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "LEVODOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1009", "mechanisms": ["Dopamine D3 receptor agonist"], "genes": ["DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE", "RESTLESS LEGS SYNDROME", "STROKE"]}, {"indications": [{"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ATROPINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146146", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "PEPTIC ULCER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "ROTIGOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 3, "name": "CEBRANOPADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364605", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "MK-0249", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL476323", "mechanisms": ["Histamine H3 receptor inverse agonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "SCHIZOPHRENIA", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "DYSPNEA", "stage": 0}], "max_phase": 4, "name": "FENTANYL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL688", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "DYSPNEA"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "ALVIMOPAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL270190", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION", "CANCER", "DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "TRAMADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237065", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "PREMATURE EJACULATION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "RAMELTEON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1218", "mechanisms": ["Melatonin receptor agonist"], "genes": ["MTNR1B", "MTNR1A"], "type": "Small molecule", "diseases": ["INSOMNIA", "BIPOLAR DISORDER", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}], "max_phase": 4, "name": "PRAMIPEXOLE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542257", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "LIVER DISEASE", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 3, "name": "NALFURAFINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490665", "mechanisms": ["Kappa opioid receptor agonist"], "genes": ["OPRK1"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "NALOXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1718", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 3}], "max_phase": 4, "name": "TIPROLISANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL462605", "mechanisms": ["Histamine H3 receptor inverse agonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "NARCOLEPSY WITH CATAPLEXY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "BAVISANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103862", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "ABT-288", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545029", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 2, "name": "SAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426084", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EATING DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200890", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "TASIMELTEON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103822", "mechanisms": ["Melatonin receptor agonist"], "genes": ["MTNR1B", "MTNR1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "LIVER DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 3, "name": "BIFEPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218166", "mechanisms": ["Dopamine D2 receptor partial agonist", "Serotonin 1a (5-HT1a) receptor partial agonist"], "genes": ["DRD2", "HTR1A"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200854", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSORIASIS", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE ENANTHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200951", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "PSORIASIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "CARIPRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517", "mechanisms": ["Dopamine D2 receptor modulator", "Dopamine D3 receptor modulator"], "genes": ["DRD2", "DRD3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "METHYLDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL459", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PREECLAMPSIA", "HYPERTENSION"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}], "max_phase": 3, "name": "ROLOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103819", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE", "CONGESTIVE HEART FAILURE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "ANGINA PECTORIS", "stage": 2}], "max_phase": 2, "name": "Capadenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3235279", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "STROKE", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "PICLOZOTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL345237", "mechanisms": ["Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": ["STROKE", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "TEMPORAL LOBE EPILEPSY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 3, "name": "NALUZOTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL209821", "mechanisms": ["Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": ["TEMPORAL LOBE EPILEPSY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "SEXUAL DYSFUNCTION", "stage": 2}], "max_phase": 4, "name": "BUSPIRONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200399", "mechanisms": ["Serotonin 1a (5-HT1a) receptor partial agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": ["SEXUAL DYSFUNCTION", "ANXIETY DISORDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Dopamine receptor agonist", "Adrenergic receptor alpha antagonist", "Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["DRD4", "DRD2", "ADRA2A", "DRD3", "HTR1A", "ADRA2C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "APOMORPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1616", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "LEVOMEPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1764", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "ROPINIROLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200411", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "DEZOCINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685", "mechanisms": ["Kappa opioid receptor antagonist", "Mu opioid receptor partial agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AXOMADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107731", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist", "Delta opioid receptor agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "OPIOID DEPENDENCE", "stage": 4}], "max_phase": 4, "name": "Buprenorphine Hydrochloride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2368861", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284671", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "OXYMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200794", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE PHOSPHATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201099", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "NALBUPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201132", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "NALTREXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201149", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}], "max_phase": 4, "name": "NALMEFENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201152", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "COUGH", "stage": 4}], "max_phase": 4, "name": "CODEINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201463", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["COUGH"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "ODELEPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103878", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "COGNITIVE IMPAIRMENT", "stage": 1}], "max_phase": 1, "name": "IRDABISANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1829335", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["COGNITIVE IMPAIRMENT"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 2}], "max_phase": 2, "name": "PF-03654764", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2206292", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 2}], "max_phase": 2, "name": "JNJ-17216498", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545030", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": ["NARCOLEPSY WITH CATAPLEXY"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "MEPERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1701", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "DIARRHEA", "stage": 3}], "max_phase": 4, "name": "LOPERAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1707", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["DIARRHEA"]}, {"indications": [{"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "METHADONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200825", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["SCOLIOSIS"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "METHYLNALTREXONE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201770", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "HYDROMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237055", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}], "max_phase": 4, "name": "NALDEMEDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105755", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 4}], "max_phase": 4, "name": "ELUXADOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2159122", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "METHYLSAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364619", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 3, "name": "OLICERIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2443262", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "NALDEMEDINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039508", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "AXELOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137313", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "PERPHENAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "TRIFLUPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Dopamine D2 receptor antagonist", "Dopamine D3 receptor antagonist"], "genes": ["DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 3}], "max_phase": 3, "name": "PRIDOPIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596802", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Dopamine D2 receptor partial agonist", "Serotonin 1a (5-HT1a) receptor partial agonist"], "genes": ["DRD2", "HTR1A"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 3, "name": "PARDOPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103832", "mechanisms": ["Dopamine receptors; D2 & D3 partial agonist", "Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["DRD2", "DRD3", "HTR1A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1705", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}], "max_phase": 4, "name": "TIZANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200329", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["SPASTICITY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "GUANFACINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200494", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "BONE NEOPLASM", "stage": 1}], "max_phase": 4, "name": "GUANABENZ ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200560", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["BONE NEOPLASM"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "PBF-680", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545162", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 2}], "max_phase": 2, "name": "BAY1067197", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545405", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE"]}, {"indications": [{"efo_term": "OCULAR HYPERTENSION", "stage": 3}], "max_phase": 3, "name": "Trabodenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545407", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "VILAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615374", "mechanisms": ["Serotonin 1a (5-HT1a) receptor partial agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 2, "name": "GSK163090", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1631540", "mechanisms": ["Serotonin 1a (5-HT1a) receptor antagonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "VORTIOXETINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107387", "mechanisms": ["Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 1}], "max_phase": 4, "name": "PROPANTHELINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "SOLIFENACIN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200803", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "FESOTERODINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201765", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "TOLTERODINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722209", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "TROSPIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3084748", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [], "max_phase": 3, "name": "SARIZOTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146110", "mechanisms": ["Dopamine D4 receptor agonist", "Dopamine D2 receptor partial agonist", "Dopamine D3 receptor agonist", "Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3", "HTR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PERGOLIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299400", "mechanisms": ["Kappa opioid receptor partial agonist", "Mu opioid receptor partial agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200543", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201047", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALLORPHAN TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062276", "mechanisms": ["Kappa opioid receptor partial agonist", "Mu opioid receptor antagonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROCODONE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201470", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GSK189254", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517140", "mechanisms": ["Histamine H3 receptor antagonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CIPRALISANT MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106003", "mechanisms": ["Histamine H3 receptor agonist"], "genes": ["HRH3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200531", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIFENOXIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200599", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYCODONE TEREPHTHALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200611", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENOXYLATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200665", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOMETHADYL ACETATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200817", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "REMIFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201120", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FENTANYL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201159", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SUFENTANIL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201163", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE NAPSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237085", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237104", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062261", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIHYDROCODEINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062266", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FAXELADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103829", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FRAKEFAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105081", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NALOXEGOL OXALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219416", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BEVENOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039511", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Naltalimide", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545408", "mechanisms": ["Mu opioid receptor partial agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200587", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENZQUINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200707", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLUPHENAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200792", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200856", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201074", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE EDISYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201154", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "APLINDORE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104864", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACETOPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2360079", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Ordopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545010", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Seridopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545388", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVONORDEFRIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "APRACLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200379", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYLDOPATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200432", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXMEDETOMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106195", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FADOLMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106710", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ETILEVODOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823681", "mechanisms": ["Dopamine D3 receptor agonist"], "genes": ["DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "FK453", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440115", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "TONAPOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414157", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TECADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL392149", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Derenofylline", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592435", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SELODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107371", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NAXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107805", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS-9667", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545011", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GW493838", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545223", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RPR749", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545331", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "BEFIRADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45305", "mechanisms": ["Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYSERGIDE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200938", "mechanisms": ["Serotonin 1a (5-HT1a) receptor partial agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ROBALZOTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628569", "mechanisms": ["Serotonin 1a (5-HT1a) receptor antagonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "OSEMOZOTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742408", "mechanisms": ["Serotonin 1a (5-HT1a) receptor agonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "LECOZOTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107349", "mechanisms": ["Serotonin 1a (5-HT1a) receptor antagonist"], "genes": ["HTR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYBUTYNIN CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETHANECHOL CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1768", "mechanisms": ["Muscarinic acetylcholine receptor M2 agonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DARIFENACIN HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200935", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DAROTROPIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103803", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}], "heat": 0.9438536336598571, "nodes": [{"assoc": 1.0, "id": "ENSG00000069696", "label": "DRD4"}, {"assoc": 0.875, "id": "ENSG00000082556", "label": "OPRK1"}, {"assoc": 0.888809621238, "id": "ENSG00000101180", "label": "HRH3"}, {"assoc": 0.974119027778, "id": "ENSG00000112038", "label": "OPRM1"}, {"assoc": 0.7, "id": "ENSG00000116329", "label": "OPRD1"}, {"assoc": 1.0, "id": "ENSG00000134640", "label": "MTNR1B"}, {"assoc": 1.0, "id": "ENSG00000149295", "label": "DRD2"}, {"assoc": 1.0, "id": "ENSG00000150594", "label": "ADRA2A"}, {"assoc": 1.0, "id": "ENSG00000151577", "label": "DRD3"}, {"assoc": 0.776022222222, "id": "ENSG00000163485", "label": "ADORA1"}, {"assoc": 1.0, "id": "ENSG00000168412", "label": "MTNR1A"}, {"assoc": 1.0, "id": "ENSG00000178394", "label": "HTR1A"}, {"assoc": 1.0, "id": "ENSG00000181072", "label": "CHRM2"}, {"assoc": 1.0, "id": "ENSG00000184160", "label": "ADRA2C"}], "size": 14}, {"diseases": ["SCHIZOPHRENIA", "PSYCHOSIS", "BIPOLAR DISORDER", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER", "ACUTE MYELOID LEUKEMIA", "NEONATAL ABSTINENCE SYNDROME", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER", "EATING DISORDER", "HUNTINGTON DISEASE", "GAMBLING BEHAVIOUR", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "HIV INFECTION", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "LYMPHOID NEOPLASM", "BREAST CARCINOMA", "ASTHMA", "NICOTINE DEPENDENCE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN", "INSOMNIA", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "MENTAL OR BEHAVIOURAL DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "POSTPARTUM DEPRESSION", "AMYOTROPHIC LATERAL SCLEROSIS", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "ACUTE CORONARY SYNDROME", "MIGRAINE DISORDER", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "PAIN", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "MULTIPLE SCLEROSIS", "PARKINSON'S DISEASE", "BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS", "HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "CARDIOVASCULAR DISEASE", "CATARACT", "CARDIAC ARRHYTHMIA", "STROKE", "HYPERPLASIA", "NEUROGENIC BLADDER", "ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "CHRONIC KIDNEY DISEASE", "MULTIPLE SYSTEM ATROPHY", "URINARY INCONTINENCE", "HYPERHIDROSIS", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "AMBLYOPIA", "DIGESTIVE SYSTEM DISEASE", "HYPOGLYCEMIA", "MYOPIA", "EMPHYSEMA", "CHRONIC BRONCHITIS", "DROOLING", "FAMILIAL DYSAUTONOMIA", "PEPTIC ULCER", "CYSTIC FIBROSIS", "ANXIETY", "HYPONATREMIA", "SEPTIC SHOCK", "NOCTURIA", "INTRACEREBRAL HEMORRHAGE", "NAUSEA", "ALLERGY", "RHINITIS, ALLERGIC, PERENNIAL", "ATOPIC ECZEMA", "ECZEMA", "PRURITUS", "SKIN DISEASE", "NEUROTIC DISORDER", "VASOMOTOR RHINITIS", "EYE ALLERGY"], "links": [{"source": "ENSG00000102468", "target": "ENSG00000120907"}, {"source": "ENSG00000102468", "target": "ENSG00000133019"}, {"source": "ENSG00000102468", "target": "ENSG00000166148"}, {"source": "ENSG00000102468", "target": "ENSG00000168539"}, {"source": "ENSG00000102468", "target": "ENSG00000170214"}, {"source": "ENSG00000102468", "target": "ENSG00000171873"}, {"source": "ENSG00000102468", "target": "ENSG00000196639"}, {"source": "ENSG00000120907", "target": "ENSG00000133019"}, {"source": "ENSG00000120907", "target": "ENSG00000166148"}, {"source": "ENSG00000120907", "target": "ENSG00000168539"}, {"source": "ENSG00000120907", "target": "ENSG00000170214"}, {"source": "ENSG00000120907", "target": "ENSG00000171873"}, {"source": "ENSG00000120907", "target": "ENSG00000196639"}, {"source": "ENSG00000133019", "target": "ENSG00000166148"}, {"source": "ENSG00000133019", "target": "ENSG00000168539"}, {"source": "ENSG00000133019", "target": "ENSG00000170214"}, {"source": "ENSG00000133019", "target": "ENSG00000171873"}, {"source": "ENSG00000133019", "target": "ENSG00000196639"}, {"source": "ENSG00000166148", "target": "ENSG00000168539"}, {"source": "ENSG00000166148", "target": "ENSG00000170214"}, {"source": "ENSG00000166148", "target": "ENSG00000171873"}, {"source": "ENSG00000166148", "target": "ENSG00000196639"}, {"source": "ENSG00000168539", "target": "ENSG00000170214"}, {"source": "ENSG00000168539", "target": "ENSG00000171873"}, {"source": "ENSG00000168539", "target": "ENSG00000196639"}, {"source": "ENSG00000170214", "target": "ENSG00000171873"}, {"source": "ENSG00000170214", "target": "ENSG00000196639"}, {"source": "ENSG00000171873", "target": "ENSG00000196639"}], "drugs": [{"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGY", "stage": 4}, {"efo_term": "URTICARIA", "stage": 3}, {"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "DESLORATADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1172", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "URTICARIA", "ATOPIC ECZEMA", "SEASONAL ALLERGIC RHINITIS", "FISH-EYE DISEASE", "ALLERGY", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "NEUROGENIC BLADDER", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 3}, {"efo_term": "URINARY INCONTINENCE", "stage": 3}, {"efo_term": "ENURESIS NOCTURNA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "OXYBUTYNIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1231", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "SEASONAL ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}, {"efo_term": "AMBLYOPIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MYOPIA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}, {"efo_term": "HYPOGLYCEMIA", "stage": 0}], "max_phase": 4, "name": "ATROPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["AMBLYOPIA", "SEASONAL ALLERGIC RHINITIS", "PAIN", "DIGESTIVE SYSTEM DISEASE", "HYPOGLYCEMIA", "MYOPIA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}], "max_phase": 4, "name": "IPRATROPIUM BROMIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2134724", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NASAL OBSTRUCTION", "OBSTRUCTIVE LUNG DISEASE", "EMPHYSEMA", "FAMILIAL DYSAUTONOMIA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "CYSTIC FIBROSIS", "stage": 3}], "max_phase": 4, "name": "TIOTROPIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545181", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CYSTIC FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "CHRONIC BRONCHITIS", "EMPHYSEMA"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}, {"efo_term": "CEREBRAL PALSY", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CYCLOBENZAPRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200636", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "PAIN"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 2}, {"efo_term": "PROSTATITIS", "stage": 2}], "max_phase": 4, "name": "SILODOSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24778", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS"]}, {"indications": [{"efo_term": "SEPTIC SHOCK", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "VASOPRESSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742", "mechanisms": ["Vasopressin receptor agonist"], "genes": ["AVPR1A"], "type": "Protein", "diseases": ["SEPTIC SHOCK", "UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "SUDDEN CARDIAC ARREST", "INJURY"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "VASOMOTOR RHINITIS", "stage": 4}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "AZELASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200809", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC CONJUNCTIVITIS", "VASOMOTOR RHINITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}, {"efo_term": "HYPERPLASIA", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}], "max_phase": 4, "name": "TAMSULOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200914", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "HYPERPLASIA", "POST-OPERATIVE SIGN OR SYMPTOM", "NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "UMECLIDINIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL523299", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "ACLIDINIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "DROOLING", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "GLYCOPYRROLATE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "DROOLING", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ATROPINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146146", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "PEPTIC ULCER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "ENURESIS NOCTURNA", "stage": 4}, {"efo_term": "NOCTURIA", "stage": 3}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 2}], "max_phase": 4, "name": "DESMOPRESSIN ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200556", "mechanisms": ["Vasopressin receptor agonist"], "genes": ["AVPR1A"], "type": "Protein", "diseases": ["ENURESIS NOCTURNA", "NOCTURIA", "INTRACEREBRAL HEMORRHAGE", "POST-OPERATIVE SIGN OR SYMPTOM"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 2}], "max_phase": 4, "name": "LORATADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGY", "PAIN", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 3}, {"efo_term": "ECZEMA", "stage": 3}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "KETOTIFEN FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1633", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "ALLERGIC CONJUNCTIVITIS", "ECZEMA", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "PRURITUS", "stage": 4}], "max_phase": 4, "name": "OLOPATADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1719", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC CONJUNCTIVITIS", "PRURITUS"]}, {"indications": [{"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SKIN DISEASE", "stage": 4}, {"efo_term": "NEUROTIC DISORDER", "stage": 4}, {"efo_term": "PRURITUS", "stage": 4}], "max_phase": 4, "name": "HYDROXYZINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200467", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["URTICARIA", "SKIN DISEASE", "NEUROTIC DISORDER", "PRURITUS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}], "max_phase": 4, "name": "CETIRIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201113", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "URTICARIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 4, "name": "PIMAVANSERIN TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2448613", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}], "max_phase": 4, "name": "ALFUZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["KIDNEY STONE", "BENIGN PROSTATIC HYPERPLASIA"]}, {"indications": [{"efo_term": "CATARACT", "stage": 3}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 1}], "max_phase": 4, "name": "PHENYLEPHRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200339", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CATARACT", "CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "URINARY INCONTINENCE", "stage": 1}], "max_phase": 4, "name": "PILOCARPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL550", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist", "Muscarinic acetylcholine receptor M1 agonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["GLAUCOMA", "URINARY INCONTINENCE"]}, {"indications": [{"efo_term": "DROOLING", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 4, "name": "TROPICAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200604", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["DROOLING", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 1}], "max_phase": 2, "name": "SRX246", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL244243", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": ["ANXIETY", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "HYPONATREMIA", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CONIVAPTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201108", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": ["HYPONATREMIA", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "BENZTROPINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "PAIN"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 1}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "DIPHENHYDRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1620", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY", "ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}, {"efo_term": "ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "FEXOFENADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200618", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201190", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["FISH-EYE DISEASE", "URTICARIA"]}, {"indications": [{"efo_term": "EYE ALLERGY", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}], "max_phase": 4, "name": "ALCAFTADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201747", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["EYE ALLERGY", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "BEPOTASTINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201759", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC CONJUNCTIVITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "VOLINANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74355", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "EPLIVANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL257704", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "NELOTANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL598172", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ACUTE CORONARY SYNDROME", "stage": 1}], "max_phase": 1, "name": "TEMANOGREL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084617", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ACUTE CORONARY SYNDROME"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}], "max_phase": 4, "name": "TRAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200798", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Alpha-1a adrenergic receptor antagonist"], "genes": ["HTR2A", "ADRA1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Histamine H1 receptor antagonist"], "genes": ["HTR2A", "HRH1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "MIDODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200461", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["STROKE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PHENYLEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062264", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARBACHOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 1}], "max_phase": 4, "name": "PROPANTHELINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 3}], "max_phase": 4, "name": "PILOCARPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200330", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist", "Muscarinic acetylcholine receptor M1 agonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "METHACHOLINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200764", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "SOLIFENACIN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200803", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}], "max_phase": 4, "name": "CLIDINIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200950", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": ["DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "FESOTERODINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201765", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "TOLTERODINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722209", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "Tarafenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1779046", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "TROSPIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3084748", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD8683", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545222", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "SEPTIC SHOCK", "stage": 2}], "max_phase": 2, "name": "SELEPRESSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1817709", "mechanisms": ["Vasopressin V1a receptor agonist"], "genes": ["AVPR1A"], "type": "Protein", "diseases": ["SEPTIC SHOCK"]}, {"indications": [{"efo_term": "AUTISM", "stage": 2}], "max_phase": 2, "name": "RG7314", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545342", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": ["AUTISM"]}, {"indications": [{"efo_term": "NAUSEA", "stage": 4}], "max_phase": 4, "name": "SCOPOLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1187846", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": ["NAUSEA"]}, {"indications": [{"efo_term": "INJURY", "stage": 3}], "max_phase": 4, "name": "BIPERIDEN LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201067", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": ["INJURY"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}], "max_phase": 4, "name": "ASTEMIZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}], "max_phase": 4, "name": "ACRIVASTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1224", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "CHLORPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1659", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}], "max_phase": 4, "name": "CYPROHEPTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1716", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 1}], "max_phase": 4, "name": "PROMETHAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200750", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "LEVOCABASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237102", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 1}], "max_phase": 2, "name": "LY2624803", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545287", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NEFAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200492", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Adrenergic receptor alpha-1 antagonist", "Histamine H1 receptor antagonist"], "genes": ["HTR2A", "ADRA1A", "ADRA1B", "ADRA1D", "HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PRUVANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215661", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VABICASERIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104991", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "IFERANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107754", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Trelanserin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3183740", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DABUZALGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL257978", "mechanisms": ["Alpha-1a adrenergic receptor partial agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200695", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DAPIPRAZOLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201044", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201535", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRAZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1558", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXAZOSIN MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200561", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TERAZOSIN HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201091", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOXAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201103", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METARAMINOL BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062262", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist", "Histamine H1 receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D", "HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYBUTYNIN CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACETYLCHOLINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1184", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANISOTROPINE METHYLBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPENZOLATE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETHANECHOL CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1768", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROPAMIDE IODIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200347", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CYCLOPENTOLATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200473", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DICYCLOMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200479", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIDIHEXETHYL CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200771", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHEMANIL METHYLSULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200880", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYPHENCYCLIMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200891", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYPHENONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DARIFENACIN HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200935", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHSCOPOLAMINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201024", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXOCYCLIUM METHYLSULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1626570", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist", "Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CEVIMELINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218917", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist", "Muscarinic acetylcholine receptor M1 agonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DAROTROPIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103803", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM3", "CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RELCOVAPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419667", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VASOPRESSIN TANNATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201528", "mechanisms": ["Vasopressin V1a receptor agonist"], "genes": ["AVPR1A"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SRX251", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545146", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LYPRESSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200690", "mechanisms": ["Vasopressin receptor agonist"], "genes": ["AVPR1A"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIHEXYPHENIDYL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENIDOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1529", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCYCLIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1761", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200426", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CYCRIMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200828", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETHOPROPAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200970", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BIPERIDEN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201035", "mechanisms": ["Muscarinic acetylcholine receptor M1 antagonist"], "genes": ["CHRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENYLPYRALINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1564", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1653", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VAPITADINE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL539843", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXYLAMINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200392", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUCLIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200403", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIMENHYDRINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200406", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPELENNAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200446", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPROLIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200450", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200491", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CYCLIZINE LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200497", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHDILAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200532", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANTAZOLINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200550", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MECLIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200590", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXBROMPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200638", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPELENNAMINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200769", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CLEMASTINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200795", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HISTAMINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200801", "mechanisms": ["Histamine H1 receptor agonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXCHLORPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200927", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHDILAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200959", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BROMPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200961", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BROMODIPHENHYDRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200967", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARBINOXAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200974", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PYRILAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201006", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201007", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPIOMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201068", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENHYDRAMINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201089", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPHENIRAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201659", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMEPRAZINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713082", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EMEDASTINE DIFUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103739", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AZATADINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544908", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000102468", "label": "HTR2A"}, {"assoc": 1.0, "id": "ENSG00000120907", "label": "ADRA1A"}, {"assoc": 1.0, "id": "ENSG00000133019", "label": "CHRM3"}, {"assoc": 1.0, "id": "ENSG00000166148", "label": "AVPR1A"}, {"assoc": 1.0, "id": "ENSG00000168539", "label": "CHRM1"}, {"assoc": 1.0, "id": "ENSG00000170214", "label": "ADRA1B"}, {"assoc": 1.0, "id": "ENSG00000171873", "label": "ADRA1D"}, {"assoc": 1.0, "id": "ENSG00000196639", "label": "HRH1"}], "size": 8}, {"diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "SKIN ULCER", "UNIPOLAR DEPRESSION", "ASTHMA", "SMOKING CESSATION", "PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "CUTANEOUS MELANOMA", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "VENTRICULAR ARRHYTHMIA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "OVARIAN CYST", "DIABETIC FOOT", "OBESITY", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CHRONIC KIDNEY DISEASE", "MULTIPLE SYSTEM ATROPHY", "LIVER DISEASE", "DRUG DEPENDENCE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "MYOCARDIAL ISCHEMIA", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS", "PAIN", "NEOPLASM", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "PREMATURE BIRTH", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "PSYCHOSIS", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "AUTISM", "DIABETES MELLITUS", "INJURY", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "HEROIN DEPENDENCE", "EATING DISORDER", "GAMBLING BEHAVIOUR", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "HIV INFECTION", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "LYMPHOID NEOPLASM", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "MULTIPLE SCLEROSIS", "INSOMNIA", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION", "ACUTE RESPIRATORY DISTRESS SYNDROME", "AMYOTROPHIC LATERAL SCLEROSIS", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"], "links": [{"source": "ENSG00000043591", "target": "ENSG00000128271"}, {"source": "ENSG00000043591", "target": "ENSG00000169252"}, {"source": "ENSG00000043591", "target": "ENSG00000169676"}, {"source": "ENSG00000043591", "target": "ENSG00000170425"}, {"source": "ENSG00000043591", "target": "ENSG00000188778"}, {"source": "ENSG00000128271", "target": "ENSG00000169252"}, {"source": "ENSG00000128271", "target": "ENSG00000169676"}, {"source": "ENSG00000128271", "target": "ENSG00000170425"}, {"source": "ENSG00000128271", "target": "ENSG00000188778"}, {"source": "ENSG00000147246", "target": "ENSG00000169252"}, {"source": "ENSG00000169252", "target": "ENSG00000169676"}, {"source": "ENSG00000169252", "target": "ENSG00000170425"}, {"source": "ENSG00000169252", "target": "ENSG00000188778"}, {"source": "ENSG00000169676", "target": "ENSG00000170425"}, {"source": "ENSG00000169676", "target": "ENSG00000188778"}, {"source": "ENSG00000170425", "target": "ENSG00000188778"}], "drugs": [{"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "stage": 1}, {"efo_term": "CONGENITAL MYASTHENIC SYNDROME", "stage": 1}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "ALBUTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MARFAN SYNDROME", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}], "max_phase": 4, "name": "ATENOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "AORTIC STENOSIS", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "METOPROLOL SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200337", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "ANGINA PECTORIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "LEFT VENTRICULAR HYPERTROPHY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "MIRABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095212", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 2}, {"efo_term": "HEMANGIOMA", "stage": 2}, {"efo_term": "SKIN ULCER", "stage": 2}], "max_phase": 4, "name": "TIMOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}, {"efo_term": "CEREBRAL PALSY", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CYCLOBENZAPRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200636", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "PAIN"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "OBESITY", "stage": 2}], "max_phase": 4, "name": "SALMETEROL XINAFOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082607", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}], "max_phase": 4, "name": "ALBUTEROL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201026", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 4, "name": "NADOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CARDIOVASCULAR DISEASE", "SMOKING CESSATION", "HEMANGIOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "VILANTEROL TRIFENATATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084172", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "INDACATEROL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789842", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "PROPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1671", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 1}], "max_phase": 4, "name": "TIMOLOL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200870", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "HEMANGIOMA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD5"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "PINDOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500", "mechanisms": ["Beta-1 adrenergic receptor partial agonist", "Beta-2 adrenergic receptor partial agonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "BETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1691", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "BISOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200708", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "FISH-EYE DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "VENTRICULAR ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "ACEBUTOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200813", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "VENTRICULAR ARRHYTHMIA"]}, {"indications": [{"efo_term": "OVARIAN CYST", "stage": 1}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "ESMOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201115", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["OVARIAN CYST", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}, {"efo_term": "OBESITY", "stage": 1}], "max_phase": 4, "name": "LORCASERIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095211", "mechanisms": ["Serotonin 2c (5-HT2c) receptor agonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["OBESITY", "SMOKING CESSATION"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}], "max_phase": 4, "name": "TERBUTALINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160544", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "METAPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200812", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "ARFORMOTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1951071", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "OLODATEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105743", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "BEDORADRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}], "max_phase": 4, "name": "FORMOTEROL FUMARATE DIHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2303638", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "ABEDITEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039530", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD3199", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545103", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "DOPAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1557", "mechanisms": ["Beta-1 adrenergic receptor agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "NEBIVOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201731", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}], "max_phase": 4, "name": "METOPROLOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256957", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist", "Beta-3 adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}], "max_phase": 4, "name": "TRAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200798", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "CARMOTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094785", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PIRBUTEROL ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200444", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 3}], "max_phase": 4, "name": "LEVALBUTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062258", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD5"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD5"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 1}], "max_phase": 3, "name": "RITOBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107773", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "VIBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107826", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENBUTOLOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200363", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOBUTAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200418", "mechanisms": ["Beta-1 adrenergic receptor agonist", "Beta-2 adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXPRENOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200745", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200837", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200898", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METIPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200947", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBUNOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200426", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NEFAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200492", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYSERGIDE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200938", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VABICASERIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104991", "mechanisms": ["Serotonin 2c (5-HT2c) receptor agonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Serotonin 2c (5-HT2c) receptor antagonist"], "genes": ["HTR2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BITOLTEROL MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTOKYLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALBUTEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201061", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201153", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RITODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201160", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MILVETEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1940832", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GSK159802", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545087", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PERGOLIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS 6201", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL260933", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS101057", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1672627", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "QAF805", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545204", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RAFABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279260", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SOLABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL208427", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AMIBEGRON HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545437", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}], "heat": 0.9674603174602857, "nodes": [{"assoc": 1.0, "id": "ENSG00000043591", "label": "ADRB1"}, {"assoc": 1.0, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 1.0, "id": "ENSG00000147246", "label": "HTR2C"}, {"assoc": 1.0, "id": "ENSG00000169252", "label": "ADRB2"}, {"assoc": 1.0, "id": "ENSG00000169676", "label": "DRD5"}, {"assoc": 0.772222222222, "id": "ENSG00000170425", "label": "ADORA2B"}, {"assoc": 1.0, "id": "ENSG00000188778", "label": "ADRB3"}], "size": 7}, {"diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "ATRIAL FIBRILLATION", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"], "links": [{"source": "ENSG00000136531", "target": "ENSG00000183873"}, {"source": "ENSG00000136531", "target": "ENSG00000185313"}, {"source": "ENSG00000136531", "target": "ENSG00000196876"}, {"source": "ENSG00000183873", "target": "ENSG00000185313"}, {"source": "ENSG00000183873", "target": "ENSG00000196876"}, {"source": "ENSG00000185313", "target": "ENSG00000196876"}, {"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000149575"}, {"source": "ENSG00000149575", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000105711"}, {"source": "ENSG00000105711", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000105711"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000149575"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000177098"}, {"source": "ENSG00000177098", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000165059"}, {"source": "ENSG00000165059", "type": "manual", "target": "ENSG00000183873"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000072062"}, {"source": "ENSG00000072062", "type": "manual", "target": "ENSG00000183873"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000183943"}, {"source": "ENSG00000183943", "type": "manual", "target": "ENSG00000183873"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000142875"}, {"source": "ENSG00000142875", "type": "manual", "target": "ENSG00000183873"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000166257"}, {"source": "ENSG00000166257", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000149575"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000105711"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "GSK-690693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494089", "mechanisms": ["cAMP-dependent protein kinase (PKA) inhibitor"], "genes": ["PRKACG", "PRKACA", "PRKACB"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN1A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": []}], "heat": 0.4666666666666667, "nodes": [{"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000144285", "label": "SCN1A"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000149575", "label": "SCN2B"}, {"assoc": 0, "id": "ENSG00000105711", "label": "SCN1B"}, {"assoc": 0, "id": "ENSG00000177098", "label": "SCN4B"}, {"assoc": 0, "id": "ENSG00000165059", "label": "PRKACG"}, {"assoc": 0, "id": "ENSG00000072062", "label": "PRKACA"}, {"assoc": 0, "id": "ENSG00000183943", "label": "PRKX"}, {"assoc": 0, "id": "ENSG00000142875", "label": "PRKACB"}, {"assoc": 0, "id": "ENSG00000166257", "label": "SCN3B"}], "size": 15}, {"diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE", "ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "PARKINSON'S DISEASE", "BIPOLAR DISORDER", "OPIOID DEPENDENCE", "CONSTIPATION", "SKIN DISEASE", "ANGINA PECTORIS", "HYPERTENSION", "INTRACEREBRAL HEMORRHAGE", "CORONARY ARTERY DISEASE", "PROTEINURIA", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "ATRIAL FIBRILLATION", "SCOLIOSIS", "INSOMNIA", "PAIN", "PRURITUS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "MOVEMENT DISORDER", "GLIOBLASTOMA MULTIFORME", "FEVER"], "links": [{"source": "ENSG00000081248", "target": "ENSG00000102001"}, {"source": "ENSG00000081248", "target": "ENSG00000148408"}, {"source": "ENSG00000081248", "target": "ENSG00000151067"}, {"source": "ENSG00000081248", "target": "ENSG00000157388"}, {"source": "ENSG00000102001", "target": "ENSG00000148408"}, {"source": "ENSG00000102001", "target": "ENSG00000151067"}, {"source": "ENSG00000102001", "target": "ENSG00000157388"}, {"source": "ENSG00000148408", "target": "ENSG00000151067"}, {"source": "ENSG00000148408", "target": "ENSG00000157388"}, {"source": "ENSG00000151067", "target": "ENSG00000157388"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1S", "CACNA1F", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1S", "CACNA1F", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "PANIC DISORDER", "stage": 3}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LEVETIRACETAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "PRINZMETAL'S ANGINA", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 3}], "max_phase": 4, "name": "AMLODIPINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200402", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CORONARY ARTERY DISEASE", "PROTEINURIA", "ANGINA PECTORIS", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "STROKE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "BRAIN ANEURYSM", "stage": 1}], "max_phase": 4, "name": "NIMODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "ANAL FISSURE", "stage": 2}], "max_phase": 4, "name": "NIFEDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ISRADIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CARDIOVASCULAR DISEASE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "ANAL FISSURE", "stage": 3}, {"efo_term": "CONSTIPATION", "stage": 1}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "DILTIAZEM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CONSTIPATION", "ANAL FISSURE", "SKIN DISEASE", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1S", "CACNA1F", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "CLEVIDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCOLIOSIS", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "NICARDIPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200326", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "INTRACEREBRAL HEMORRHAGE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1S", "CACNA1F", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "ZICONOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Protein", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "FELODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "NISOLDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1S", "CACNA1F", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "CNV2197944", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545172", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated L-type calcium channel blocker", "Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VERAPAMIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DILTIAZEM MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200805", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMLODIPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200984", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Z160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL604710", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}], "heat": 0.8191439777776001, "nodes": [{"assoc": 0.772222222222, "id": "ENSG00000081248", "label": "CACNA1S"}, {"assoc": 0.772222222222, "id": "ENSG00000102001", "label": "CACNA1F"}, {"assoc": 1.0, "id": "ENSG00000148408", "label": "CACNA1B"}, {"assoc": 0.779053222222, "id": "ENSG00000151067", "label": "CACNA1C"}, {"assoc": 0.772222222222, "id": "ENSG00000157388", "label": "CACNA1D"}], "size": 5}, {"diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE MYELOID LEUKEMIA", "BREAST CARCINOMA", "LYMPHOMA", "LEUKEMIA", "SARCOMA", "PROSTATE CARCINOMA", "NEOPLASM", "HISTIOCYTOSIS", "ACUTE PROMYELOCYTIC LEUKEMIA", "LUNG CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "BLADDER CARCINOMA", "MESOTHELIOMA", "OVARIAN CARCINOMA", "MYELODYSPLASTIC SYNDROME", "NEOPLASM OF MATURE B-CELLS", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "CHRONIC MYELOMONOCYTIC LEUKEMIA", "SICKLE CELL ANEMIA", "APLASTIC ANEMIA", "LYMPHOID LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "CUTANEOUS MELANOMA"], "links": [{"source": "ENSG00000062822", "target": "ENSG00000101868"}, {"source": "ENSG00000062822", "target": "ENSG00000140521"}, {"source": "ENSG00000062822", "target": "ENSG00000177084"}, {"source": "ENSG00000101868", "target": "ENSG00000177084"}], "drugs": [{"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "HISTIOCYTOSIS", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC MYELOMONOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "CLOFARABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1750", "mechanisms": ["DNA polymerase (alpha/delta/epsilon) inhibitor"], "genes": ["POLD1", "POLA1", "POLE"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MYELODYSPLASTIC SYNDROME", "ACUTE MYELOID LEUKEMIA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "NEOPLASM", "NEOPLASM OF MATURE B-CELLS", "MULTIPLE MYELOMA", "HISTIOCYTOSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "CHRONIC MYELOMONOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 3}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "HISTIOCYTOSIS", "stage": 3}, {"efo_term": "ACUTE PROMYELOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CYTARABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL803", "mechanisms": ["DNA polymerase (alpha/delta/epsilon) inhibitor"], "genes": ["POLD1", "POLA1", "POLE"], "type": "Small molecule", "diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE MYELOID LEUKEMIA", "BREAST CARCINOMA", "LYMPHOMA", "LEUKEMIA", "SARCOMA", "PROSTATE CARCINOMA", "NEOPLASM", "HISTIOCYTOSIS", "ACUTE PROMYELOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "OVARIAN CARCINOMA", "stage": 4}, {"efo_term": "BLADDER CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "GEMCITABINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1637", "mechanisms": ["DNA polymerase (alpha/delta/epsilon) inhibitor"], "genes": ["POLD1", "POLA1", "POLE"], "type": "Small molecule", "diseases": ["LUNG CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "BLADDER CARCINOMA", "BREAST CARCINOMA", "LEUKEMIA", "MESOTHELIOMA", "OVARIAN CARCINOMA", "SARCOMA"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "LYMPHOID LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "SARCOMA", "stage": 1}, {"efo_term": "APLASTIC ANEMIA", "stage": 1}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 1}], "max_phase": 4, "name": "FLUDARABINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096882", "mechanisms": ["DNA polymerase (alpha/delta/epsilon) inhibitor"], "genes": ["POLD1", "POLA1", "POLE"], "type": "Small molecule", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA", "ACUTE MYELOID LEUKEMIA", "NEOPLASM", "SARCOMA", "SICKLE CELL ANEMIA", "APLASTIC ANEMIA", "LYMPHOID LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "CUTANEOUS MELANOMA"]}], "heat": 0.541957788488725, "nodes": [{"assoc": 0.7, "id": "ENSG00000062822", "label": "POLD1"}, {"assoc": 0.7, "id": "ENSG00000101868", "label": "POLA1"}, {"assoc": 0.0678311539549, "id": "ENSG00000140521", "label": "POLG"}, {"assoc": 0.7, "id": "ENSG00000177084", "label": "POLE"}], "size": 4}, {"diseases": ["GLAUCOMA", "EPILEPSY", "KIDNEY DISEASE", "HELICOBACTER PYLORI INFECTION", "CARDIODYSRHYTHMIC POTASSIUM-SENSITIVE PERIODIC PARALYSIS", "ALTITUDE SICKNESS", "PULMONARY HYPERTENSION", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "MULTIPLE SCLEROSIS", "OSTEOARTHRITIS, HIP", "OSTEOARTHRITIS", "OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "COCAINE DEPENDENCE", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"], "links": [{"source": "ENSG00000080493", "target": "ENSG00000104267"}, {"source": "ENSG00000080493", "target": "ENSG00000167434"}], "drugs": [{"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "ALTITUDE SICKNESS", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "KIDNEY DISEASE", "stage": 2}, {"efo_term": "HELICOBACTER PYLORI INFECTION", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CARDIODYSRHYTHMIC POTASSIUM-SENSITIVE PERIODIC PARALYSIS", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "ACETAZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["EPILEPSY", "GLAUCOMA", "KIDNEY DISEASE", "HELICOBACTER PYLORI INFECTION", "CARDIODYSRHYTHMIC POTASSIUM-SENSITIVE PERIODIC PARALYSIS", "ALTITUDE SICKNESS", "PULMONARY HYPERTENSION", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "BRINZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491", "mechanisms": ["Carbonic anhydrase II inhibitor"], "genes": ["CA2"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "GLAUCOMA"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}], "max_phase": 3, "name": "POLMACOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL166863", "mechanisms": ["Carbonic anhydrase II inhibitor"], "genes": ["CA2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, HIP", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "ACETAZOLAMIDE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200814", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["EPILEPSY", "GLAUCOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "DICHLORPHENAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "METHAZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [], "max_phase": 4, "name": "DORZOLAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201162", "mechanisms": ["Carbonic anhydrase II inhibitor"], "genes": ["CA2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETHOXZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18", "mechanisms": ["Carbonic anhydrase inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": []}], "heat": 0.13996666666666668, "nodes": [{"assoc": 0.0199, "id": "ENSG00000080493", "label": "SLC4A4"}, {"assoc": 0.2, "id": "ENSG00000104267", "label": "CA2"}, {"assoc": 0.2, "id": "ENSG00000167434", "label": "CA4"}], "size": 3}, {"diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION", "HYPERTENSION", "OVERACTIVE BLADDER", "GASTROPARESIS", "IRRITABLE BOWEL SYNDROME", "LIVER DISEASE", "TYPE II DIABETES MELLITUS", "ASTHMA"], "links": [{"source": "ENSG00000101204", "target": "ENSG00000160716"}, {"source": "ENSG00000101204", "target": "ENSG00000175344"}, {"source": "ENSG00000160716", "target": "ENSG00000175344"}], "drugs": [{"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CERVICAL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 1}, {"efo_term": "SARCOIDOSIS", "stage": 1}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 4, "name": "NICOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "ISPRONICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188462", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 1}], "max_phase": 3, "name": "DEXMECAMYLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103881", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["HYPERTENSION", "OVERACTIVE BLADDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "POZANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127071", "mechanisms": ["Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist", "Neuronal acetylcholine receptor; alpha6/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "BRADANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1258006", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "SOFINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL238465", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "NICOTINE POLACRILEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201536", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 1}], "max_phase": 4, "name": "VARENICLINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062259", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "AZD1446", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2179529", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "GASTROPARESIS", "stage": 1}], "max_phase": 2, "name": "TC-6499", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545353", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "AZD0328", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2151437", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "ABT-126", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545231", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "JNJ-39393406", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545291", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SMOKING CESSATION", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "TC-6987", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545410", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit modulator"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 1, "name": "AVL-3288", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429317", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "SSR180711", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559478", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "ENCENICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2151572", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["LIVER DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "RG3487", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544952", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 1, "name": "APN1125", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545013", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "AQW051", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545232", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 0, "name": "ND0801", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707316", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [], "max_phase": 2, "name": "TEBANICLINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430497", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ALTINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111659", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TC-2216", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504652", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CP-601927", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707250", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ABT-560", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707354", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 modulator"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PHA-543613", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL214268", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ABT-107", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2151570", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": []}], "heat": 0.7284744796296666, "nodes": [{"assoc": 1.0, "id": "ENSG00000101204", "label": "CHRNA4"}, {"assoc": 1.0, "id": "ENSG00000160716", "label": "CHRNB2"}, {"assoc": 0.185423438889, "id": "ENSG00000175344", "label": "CHRNA7"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000125650", "target": "ENSG00000171119"}, {"source": "ENSG00000168546", "target": "ENSG00000171119"}], "drugs": [], "heat": 0.05910122167773333, "nodes": [{"assoc": 0.0607974444444, "id": "ENSG00000125650", "label": "PSPN"}, {"assoc": 0.034848, "id": "ENSG00000168546", "label": "GFRA2"}, {"assoc": 0.0816582205888, "id": "ENSG00000171119", "label": "NRTN"}], "size": 3}], "auto_delta": "0.00199056"}